Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-92a-3p ABCA3 2.06 0 -1.39 0.0022 miRNAWalker2 validate -0.3 0.00142 NA
2 hsa-miR-320a ABCA4 0.44 0.03902 0.81 0.21181 miRanda -0.39 0.00925 NA
3 hsa-miR-320b ABCA8 1.56 0 -5.33 0 miRanda -0.59 0 NA
4 hsa-miR-32-3p ABCC9 2.02 0 -2.76 0 mirMAP; miRNATAP -0.5 0 NA
5 hsa-miR-339-5p ABCC9 2.69 0 -2.76 0 miRanda -0.4 0 NA
6 hsa-miR-23b-3p ABCF1 -0.25 0.1502 0.13 0.23372 miRNAWalker2 validate -0.12 0.00018 NA
7 hsa-miR-25-3p ABHD13 1.36 0 -0.35 0.00167 miRNATAP -0.12 0 NA
8 hsa-miR-320b ABHD2 1.56 0 -0.37 0.12248 mirMAP -0.1 0.01657 NA
9 hsa-miR-339-5p ABHD2 2.69 0 -0.37 0.12248 PITA -0.1 0.00324 NA
10 hsa-miR-140-3p ABI2 0.06 0.72772 -0.65 0 miRNATAP -0.16 2.0E-5 NA
11 hsa-miR-32-3p ABI3BP 2.02 0 -4.28 0 mirMAP -0.59 0 NA
12 hsa-miR-320a ABI3BP 0.44 0.03902 -4.28 0 miRanda -0.65 0 NA
13 hsa-miR-320b ABI3BP 1.56 0 -4.28 0 miRanda -0.82 0 NA
14 hsa-miR-92a-3p ABI3BP 2.06 0 -4.28 0 miRNATAP -1.23 0 NA
15 hsa-miR-140-3p ABL1 0.06 0.72772 -1.32 0 MirTarget; PITA -0.14 0.0013 NA
16 hsa-miR-15b-5p ABL1 1.57 0 -1.32 0 mirMAP -0.25 0 NA
17 hsa-miR-25-3p ABLIM1 1.36 0 -1.72 0 mirMAP -0.2 0.00211 NA
18 hsa-miR-32-3p ABLIM1 2.02 0 -1.72 0 mirMAP -0.1 0.01884 NA
19 hsa-miR-92a-3p ABLIM1 2.06 0 -1.72 0 mirMAP -0.21 0.00032 NA
20 hsa-miR-339-5p ABLIM2 2.69 0 -1.01 0.01362 miRanda -0.12 0.04303 NA
21 hsa-miR-32-3p ABLIM3 2.02 0 -1.3 0.00063 mirMAP -0.19 0.00159 NA
22 hsa-miR-320a ACAN 0.44 0.03902 0.96 0.02146 miRanda -0.21 0.02776 NA
23 hsa-miR-23b-3p ACAT1 -0.25 0.1502 -1.05 0 miRNAWalker2 validate -0.23 9.0E-5 NA
24 hsa-miR-320a ACAT1 0.44 0.03902 -1.05 0 miRanda -0.25 0 NA
25 hsa-miR-320b ACAT1 1.56 0 -1.05 0 miRanda -0.18 0 NA
26 hsa-miR-320a ACBD3 0.44 0.03902 0.07 0.61626 MirTarget; miRanda -0.1 0.00079 NA
27 hsa-miR-23b-3p ACER3 -0.25 0.1502 -0.12 0.46232 MirTarget -0.15 0.00165 NA
28 hsa-miR-320a ACOT7 0.44 0.03902 0.73 0.00054 miRanda -0.15 0.00294 NA
29 hsa-miR-15b-5p ACSBG1 1.57 0 -0.87 0.10903 MirTarget -0.24 0.03787 NA
30 hsa-miR-320a ACSL4 0.44 0.03902 -0.41 0.0792 miRanda -0.17 0.00139 NA
31 hsa-miR-320b ACSL4 1.56 0 -0.41 0.0792 miRanda -0.13 0.0016 NA
32 hsa-miR-320a ACTB 0.44 0.03902 -0.54 0.00046 miRNAWalker2 validate -0.22 0 NA
33 hsa-miR-92a-3p ACTB 2.06 0 -0.54 0.00046 miRNAWalker2 validate -0.18 0 NA
34 hsa-miR-32-3p ACTBL2 2.02 0 1.68 0.00368 mirMAP -0.21 0.01831 NA
35 hsa-miR-320a ACTBL2 0.44 0.03902 1.68 0.00368 miRanda -0.68 0 NA
36 hsa-miR-25-3p ACTC1 1.36 0 -7.19 0 MirTarget -2.06 0 NA
37 hsa-miR-92a-3p ACTC1 2.06 0 -7.19 0 MirTarget -2.49 0 NA
38 hsa-miR-32-3p ACTN2 2.02 0 -3.37 0 MirTarget -0.34 0.00045 NA
39 hsa-miR-486-5p ACTN2 -0.19 0.60738 -3.37 0 miRanda -0.16 0.03925 NA
40 hsa-miR-320a ACTN4 0.44 0.03902 -0.06 0.65476 miRNAWalker2 validate -0.12 0.00024 NA
41 hsa-miR-320a ACTR2 0.44 0.03902 0.16 0.19648 miRanda -0.13 0 NA
42 hsa-miR-320a ACVR1 0.44 0.03902 -0.44 0.01143 miRanda -0.17 3.0E-5 NA
43 hsa-miR-320b ACVR1 1.56 0 -0.44 0.01143 miRanda -0.17 0 NA
44 hsa-miR-140-3p ACVR1B 0.06 0.72772 0.35 0.04863 mirMAP -0.14 0.0057 NA
45 hsa-miR-320a ADAM12 0.44 0.03902 0.88 0.05623 mirMAP -0.67 0 NA
46 hsa-miR-320b ADAM12 1.56 0 0.88 0.05623 mirMAP -0.42 0 NA
47 hsa-miR-140-3p ADAM17 0.06 0.72772 0.62 0.00628 PITA; miRNATAP -0.14 0.03535 NA
48 hsa-miR-23b-3p ADAM19 -0.25 0.1502 -1.06 0.01895 miRNATAP -0.44 0.00056 NA
49 hsa-miR-25-3p ADAM19 1.36 0 -1.06 0.01895 MirTarget; miRNATAP -0.63 0 NA
50 hsa-miR-320a ADAM19 0.44 0.03902 -1.06 0.01895 mirMAP -0.87 0 NA
51 hsa-miR-320b ADAM19 1.56 0 -1.06 0.01895 mirMAP -0.56 0 NA
52 hsa-miR-92a-3p ADAM19 2.06 0 -1.06 0.01895 MirTarget; miRNATAP -0.57 0 NA
53 hsa-miR-320b ADAM22 1.56 0 -1.12 0.02589 miRanda; mirMAP -0.2 0.02217 NA
54 hsa-miR-92a-3p ADAM23 2.06 0 -1.05 0.04992 miRNATAP -0.3 0.00553 NA
55 hsa-miR-32-3p ADAM28 2.02 0 -0.73 0.15943 mirMAP -0.28 0.00051 NA
56 hsa-miR-339-5p ADAM33 2.69 0 -4.48 0 miRanda -0.5 0 NA
57 hsa-miR-320a ADAM9 0.44 0.03902 -0.2 0.40665 miRanda -0.14 0.01076 NA
58 hsa-miR-320b ADAM9 1.56 0 -0.2 0.40665 miRanda -0.11 0.01178 NA
59 hsa-miR-92a-3p ADAMTS1 2.06 0 -3.81 0 miRNAWalker2 validate -0.74 0 NA
60 hsa-miR-320a ADAMTS14 0.44 0.03902 0.61 0.12479 miRanda -0.48 0 NA
61 hsa-miR-320b ADAMTS14 1.56 0 0.61 0.12479 miRanda -0.33 0 NA
62 hsa-miR-15b-5p ADAMTS18 1.57 0 -0.74 0.14599 miRNATAP -0.55 0 NA
63 hsa-miR-15b-5p ADAMTS3 1.57 0 -1.18 0.00448 miRNATAP -0.31 0.00061 NA
64 hsa-miR-320a ADAMTS3 0.44 0.03902 -1.18 0.00448 mirMAP -0.47 0 NA
65 hsa-miR-320b ADAMTS3 1.56 0 -1.18 0.00448 mirMAP -0.34 0 NA
66 hsa-miR-339-5p ADAMTS4 2.69 0 -2.17 0 miRanda -0.35 0 NA
67 hsa-miR-15b-5p ADAMTS5 1.57 0 -2.16 0 miRNATAP -0.49 0 NA
68 hsa-miR-32-3p ADAMTS5 2.02 0 -2.16 0 mirMAP -0.28 0 NA
69 hsa-miR-23b-3p ADAMTS6 -0.25 0.1502 -0.88 0.01914 MirTarget; miRNATAP -0.42 7.0E-5 NA
70 hsa-miR-32-3p ADAMTS6 2.02 0 -0.88 0.01914 MirTarget; mirMAP; miRNATAP -0.3 0 NA
71 hsa-miR-320a ADAMTS6 0.44 0.03902 -0.88 0.01914 miRanda -0.67 0 NA
72 hsa-miR-320b ADAMTS6 1.56 0 -0.88 0.01914 miRanda -0.49 0 NA
73 hsa-miR-320a ADAMTS9 0.44 0.03902 -1.79 0 miRanda -0.2 0.00851 NA
74 hsa-miR-320b ADAMTS9 1.56 0 -1.79 0 miRanda -0.35 0 NA
75 hsa-miR-25-3p ADAMTSL1 1.36 0 -2.52 0 miRNAWalker2 validate; miRNATAP -0.5 0 NA
76 hsa-miR-320a ADAMTSL1 0.44 0.03902 -2.52 0 miRanda; mirMAP -0.64 0 NA
77 hsa-miR-320b ADAMTSL1 1.56 0 -2.52 0 miRanda; mirMAP -0.6 0 NA
78 hsa-miR-339-5p ADAMTSL1 2.69 0 -2.52 0 miRanda -0.3 1.0E-5 NA
79 hsa-miR-486-5p ADAMTSL1 -0.19 0.60738 -2.52 0 miRanda -0.16 0.00794 NA
80 hsa-miR-92a-3p ADAMTSL1 2.06 0 -2.52 0 miRNATAP -0.78 0 NA
81 hsa-miR-15b-5p ADAMTSL3 1.57 0 -5.11 0 MirTarget -1.14 0 NA
82 hsa-miR-25-3p ADAMTSL3 1.36 0 -5.11 0 MirTarget; miRNATAP -0.96 0 NA
83 hsa-miR-32-3p ADAMTSL3 2.02 0 -5.11 0 miRNATAP -0.65 0 NA
84 hsa-miR-320a ADAMTSL3 0.44 0.03902 -5.11 0 miRanda -0.71 0 NA
85 hsa-miR-320b ADAMTSL3 1.56 0 -5.11 0 miRanda -0.73 0 NA
86 hsa-miR-486-5p ADAMTSL3 -0.19 0.60738 -5.11 0 miRanda -0.21 0.00494 NA
87 hsa-miR-92a-3p ADAMTSL3 2.06 0 -5.11 0 MirTarget; miRNATAP -1.24 0 NA
88 hsa-miR-339-5p ADAMTSL4 2.69 0 -1.86 9.0E-5 miRanda -0.21 0.00157 NA
89 hsa-miR-320a ADAR 0.44 0.03902 0.46 0.00043 miRanda -0.1 0.00071 NA
90 hsa-miR-32-3p ADARB1 2.02 0 -1.93 0 mirMAP -0.29 0 NA
91 hsa-miR-320a ADARB1 0.44 0.03902 -1.93 0 miRanda -0.55 0 NA
92 hsa-miR-320b ADARB1 1.56 0 -1.93 0 miRanda -0.42 0 NA
93 hsa-miR-15b-5p ADCY5 1.57 0 -5.17 0 MirTarget; miRNATAP -1.46 0 NA
94 hsa-miR-320a ADCY5 0.44 0.03902 -5.17 0 mirMAP -0.63 4.0E-5 NA
95 hsa-miR-320b ADCY5 1.56 0 -5.17 0 mirMAP -0.94 0 NA
96 hsa-miR-140-3p ADCY9 0.06 0.72772 -1.5 0 PITA; miRNATAP -0.2 0.00757 NA
97 hsa-miR-25-3p ADCY9 1.36 0 -1.5 0 mirMAP -0.48 0 NA
98 hsa-miR-92a-3p ADCY9 2.06 0 -1.5 0 mirMAP -0.45 0 NA
99 hsa-miR-320a ADCYAP1 0.44 0.03902 -3.51 0 PITA; miRanda; miRNATAP -0.3 0.02179 NA
100 hsa-miR-320b ADCYAP1 1.56 0 -3.51 0 PITA; miRanda; miRNATAP -0.69 0 NA
101 hsa-miR-32-3p ADH1B 2.02 0 -7.89 0 mirMAP -0.78 0 NA
102 hsa-miR-320a ADIPOQ 0.44 0.03902 -5.02 0 miRanda -0.92 0 NA
103 hsa-miR-320b ADIPOQ 1.56 0 -5.02 0 miRanda -1.2 0 NA
104 hsa-miR-339-5p ADIPOQ 2.69 0 -5.02 0 miRanda -0.54 1.0E-5 NA
105 hsa-miR-25-3p ADM 1.36 0 -0.13 0.70322 miRNATAP -0.32 5.0E-5 NA
106 hsa-miR-320a ADRA1B 0.44 0.03902 -0.45 0.38166 miRanda -0.35 0.00316 NA
107 hsa-miR-320b ADRA1B 1.56 0 -0.45 0.38166 miRanda -0.38 2.0E-5 NA
108 hsa-miR-320a ADRA1D 0.44 0.03902 -4.03 0 miRanda -0.44 4.0E-5 NA
109 hsa-miR-320b ADRA1D 1.56 0 -4.03 0 miRanda -0.51 0 NA
110 hsa-miR-339-5p ADRA2A 2.69 0 -2.58 0 miRanda -0.36 0 NA
111 hsa-miR-320b ADRB2 1.56 0 -1.96 1.0E-5 miRanda -0.16 0.0455 NA
112 hsa-miR-339-5p AES 2.69 0 -0.34 0.05857 miRanda -0.11 3.0E-5 NA
113 hsa-miR-320a AFAP1 0.44 0.03902 -0.98 0.00012 mirMAP -0.48 0 NA
114 hsa-miR-320b AFAP1 1.56 0 -0.98 0.00012 mirMAP -0.34 0 NA
115 hsa-miR-32-3p AFF2 2.02 0 -1.73 0.00201 mirMAP -0.25 0.00513 NA
116 hsa-miR-92a-3p AFF2 2.06 0 -1.73 0.00201 mirMAP -0.29 0.0105 NA
117 hsa-miR-25-3p AFF3 1.36 0 -5 0 MirTarget -0.75 0 NA
118 hsa-miR-92a-3p AFF3 2.06 0 -5 0 MirTarget -1.14 0 NA
119 hsa-miR-25-3p AFF4 1.36 0 -0.82 0 mirMAP; miRNATAP -0.13 0.00014 NA
120 hsa-miR-92a-3p AFF4 2.06 0 -0.82 0 mirMAP; miRNATAP -0.13 5.0E-5 NA
121 hsa-miR-22-3p AGBL5 1.22 0 -0.1 0.47409 MirTarget; miRNATAP -0.13 0.00076 NA
122 hsa-miR-320a AGFG1 0.44 0.03902 -0.17 0.30925 miRNATAP -0.12 0.00215 NA
123 hsa-miR-140-3p AGL 0.06 0.72772 -0.67 6.0E-5 MirTarget; PITA -0.14 0.00326 NA
124 hsa-miR-15b-5p AGPAT4 1.57 0 -0.79 0.01174 mirMAP -0.27 7.0E-5 NA
125 hsa-miR-32-3p AGPAT4 2.02 0 -0.79 0.01174 mirMAP; miRNATAP -0.2 6.0E-5 NA
126 hsa-miR-320a AGPAT4 0.44 0.03902 -0.79 0.01174 mirMAP -0.24 0.00083 NA
127 hsa-miR-320b AGPAT4 1.56 0 -0.79 0.01174 mirMAP -0.19 0.00058 NA
128 hsa-miR-140-3p AGPS 0.06 0.72772 -0.1 0.48101 PITA -0.15 8.0E-5 NA
129 hsa-miR-320a AGPS 0.44 0.03902 -0.1 0.48101 miRanda; miRNATAP -0.14 1.0E-5 NA
130 hsa-miR-320a AGTPBP1 0.44 0.03902 -0.1 0.57308 mirMAP -0.17 1.0E-5 NA
131 hsa-miR-140-3p AHDC1 0.06 0.72772 -0.69 6.0E-5 PITA; miRNATAP -0.25 0 NA
132 hsa-miR-25-3p AIDA 1.36 0 -0.31 0.01307 MirTarget; miRNATAP -0.16 0 NA
133 hsa-miR-92a-3p AIDA 2.06 0 -0.31 0.01307 miRNAWalker2 validate; MirTarget; miRNATAP -0.11 1.0E-5 NA
134 hsa-miR-320a AIF1L 0.44 0.03902 -1.46 0.00033 miRNATAP -0.32 0.00069 NA
135 hsa-miR-320b AIF1L 1.56 0 -1.46 0.00033 miRNATAP -0.17 0.01783 NA
136 hsa-miR-320a AKAP10 0.44 0.03902 -0.29 0.18561 mirMAP -0.14 0.00795 NA
137 hsa-miR-15b-5p AKAP11 1.57 0 -0.8 0 MirTarget; miRNATAP -0.16 1.0E-5 NA
138 hsa-miR-25-3p AKAP12 1.36 0 -2.95 0 mirMAP -0.27 0.0072 NA
139 hsa-miR-32-3p AKAP12 2.02 0 -2.95 0 mirMAP -0.18 0.00823 NA
140 hsa-miR-32-3p AKAP13 2.02 0 -1.15 0 mirMAP -0.19 0 NA
141 hsa-miR-320a AKAP13 0.44 0.03902 -1.15 0 miRanda -0.17 1.0E-5 NA
142 hsa-miR-320b AKAP13 1.56 0 -1.15 0 miRanda -0.2 0 NA
143 hsa-miR-339-5p AKAP13 2.69 0 -1.15 0 miRanda -0.2 0 NA
144 hsa-miR-23b-3p AKAP2 -0.25 0.1502 -2.51 8.0E-5 mirMAP -0.54 0.00257 NA
145 hsa-miR-32-3p AKAP2 2.02 0 -2.51 8.0E-5 mirMAP -0.38 0.00012 NA
146 hsa-miR-320a AKAP2 0.44 0.03902 -2.51 8.0E-5 PITA; miRanda; miRNATAP -0.86 0 NA
147 hsa-miR-320b AKAP2 1.56 0 -2.51 8.0E-5 PITA; miRanda; miRNATAP -0.57 0 NA
148 hsa-miR-423-3p AKAP2 2.58 0 -2.51 8.0E-5 PITA -0.89 0 NA
149 hsa-miR-32-3p AKAP6 2.02 0 -3.34 0 mirMAP -0.57 0 NA
150 hsa-miR-320a AKAP6 0.44 0.03902 -3.34 0 miRanda -0.67 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 409 1672 3.222e-40 1.499e-36
2 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 346 1395 4.712e-35 1.096e-31
3 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 274 1008 9.31e-35 1.444e-31
4 REGULATION OF CELL DIFFERENTIATION 362 1492 1.377e-34 1.602e-31
5 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 423 1848 2.4e-34 1.861e-31
6 REGULATION OF CELLULAR COMPONENT MOVEMENT 227 771 2.249e-34 1.861e-31
7 CELL DEVELOPMENT 348 1426 9.7e-34 5.164e-31
8 CARDIOVASCULAR SYSTEM DEVELOPMENT 229 788 9.988e-34 5.164e-31
9 CIRCULATORY SYSTEM DEVELOPMENT 229 788 9.988e-34 5.164e-31
10 VASCULATURE DEVELOPMENT 162 469 1.593e-33 7.412e-31
11 BIOLOGICAL ADHESION 275 1032 2.833e-33 1.198e-30
12 RESPONSE TO ENDOGENOUS STIMULUS 350 1450 6.386e-33 2.476e-30
13 POSITIVE REGULATION OF RESPONSE TO STIMULUS 430 1929 3.772e-32 1.35e-29
14 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 382 1656 1.371e-31 4.557e-29
15 TISSUE DEVELOPMENT 357 1518 3.457e-31 1.072e-28
16 BLOOD VESSEL MORPHOGENESIS 133 364 1.814e-30 5.16e-28
17 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 266 1021 1.885e-30 5.16e-28
18 NEUROGENESIS 334 1402 3.155e-30 8.156e-28
19 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 311 1275 5.022e-30 1.23e-27
20 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 287 1142 5.486e-30 1.276e-27
21 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 250 957 8.216e-29 1.821e-26
22 POSITIVE REGULATION OF CELL COMMUNICATION 352 1532 1.127e-28 2.383e-26
23 REGULATION OF PHOSPHORUS METABOLIC PROCESS 365 1618 3.984e-28 8.06e-26
24 INTRACELLULAR SIGNAL TRANSDUCTION 357 1572 4.536e-28 8.795e-26
25 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 195 689 3.578e-27 6.659e-25
26 LOCOMOTION 274 1114 4.975e-27 8.904e-25
27 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 215 799 1.176e-26 2.027e-24
28 POSITIVE REGULATION OF MOLECULAR FUNCTION 388 1791 2.944e-26 4.892e-24
29 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 315 1360 3.153e-26 5.06e-24
30 POSITIVE REGULATION OF LOCOMOTION 137 420 1.062e-25 1.626e-23
31 RESPONSE TO OXYGEN CONTAINING COMPOUND 317 1381 1.083e-25 1.626e-23
32 MUSCLE STRUCTURE DEVELOPMENT 139 432 2.098e-25 3.05e-23
33 CELLULAR RESPONSE TO NITROGEN COMPOUND 153 505 8.691e-25 1.225e-22
34 ANGIOGENESIS 107 293 1.036e-24 1.418e-22
35 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 250 1036 2.001e-23 2.587e-21
36 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 250 1036 2.001e-23 2.587e-21
37 REGULATION OF CELL PROLIFERATION 329 1496 2.595e-23 3.264e-21
38 NEGATIVE REGULATION OF CELL COMMUNICATION 277 1192 2.786e-23 3.412e-21
39 REGULATION OF PROTEIN MODIFICATION PROCESS 364 1710 3.835e-23 4.576e-21
40 REGULATION OF CELL DEVELOPMENT 213 836 4.059e-23 4.722e-21
41 POSITIVE REGULATION OF CELL DIFFERENTIATION 209 823 1.655e-22 1.878e-20
42 NEURON DIFFERENTIATION 218 874 2.175e-22 2.409e-20
43 CELL CELL ADHESION 168 608 2.652e-22 2.87e-20
44 PROTEIN PHOSPHORYLATION 230 944 3.67e-22 3.881e-20
45 POSITIVE REGULATION OF CATALYTIC ACTIVITY 324 1518 9.213e-21 9.526e-19
46 CELLULAR COMPONENT MORPHOGENESIS 218 900 1.049e-20 1.062e-18
47 SKELETAL SYSTEM DEVELOPMENT 134 455 1.267e-20 1.254e-18
48 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 232 983 1.85e-20 1.793e-18
49 REGULATION OF GTPASE ACTIVITY 175 673 4.008e-20 3.806e-18
50 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 141 498 6.412e-20 5.967e-18
51 CELL MOTILITY 204 835 7.059e-20 6.316e-18
52 LOCALIZATION OF CELL 204 835 7.059e-20 6.316e-18
53 RESPONSE TO NITROGEN COMPOUND 208 859 9.029e-20 7.927e-18
54 POSITIVE REGULATION OF CELL PROLIFERATION 199 814 1.915e-19 1.65e-17
55 NEURON PROJECTION DEVELOPMENT 149 545 1.995e-19 1.687e-17
56 REGULATION OF MAPK CASCADE 170 660 3.966e-19 3.264e-17
57 REGULATION OF NEURON DIFFERENTIATION 150 554 3.999e-19 3.264e-17
58 POSITIVE REGULATION OF GENE EXPRESSION 352 1733 7.539e-19 6.048e-17
59 RESPONSE TO HORMONE 211 893 9.909e-19 7.685e-17
60 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 208 876 9.89e-19 7.685e-17
61 POSITIVE REGULATION OF HYDROLASE ACTIVITY 212 905 2.323e-18 1.772e-16
62 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 311 1492 2.445e-18 1.835e-16
63 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 251 1135 3.688e-18 2.724e-16
64 REGULATION OF HYDROLASE ACTIVITY 283 1327 4.159e-18 3.024e-16
65 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 139 513 7.801e-18 5.584e-16
66 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 359 1805 1.038e-17 7.321e-16
67 PHOSPHORYLATION 265 1228 1.125e-17 7.811e-16
68 REGULATION OF CELL MORPHOGENESIS 146 552 1.16e-17 7.938e-16
69 CENTRAL NERVOUS SYSTEM DEVELOPMENT 204 872 1.243e-17 8.38e-16
70 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 252 1152 1.327e-17 8.822e-16
71 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 182 750 1.644e-17 1.063e-15
72 REGULATION OF CELL ADHESION 160 629 1.628e-17 1.063e-15
73 HEART DEVELOPMENT 128 466 4.982e-17 3.176e-15
74 NEURON DEVELOPMENT 169 687 6.253e-17 3.932e-15
75 CELLULAR RESPONSE TO HORMONE STIMULUS 144 552 7.077e-17 4.39e-15
76 EPITHELIUM DEVELOPMENT 214 945 8.998e-17 5.378e-15
77 REGULATION OF TRANSPORT 355 1804 8.939e-17 5.378e-15
78 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 61 153 9.016e-17 5.378e-15
79 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 382 1977 1.001e-16 5.854e-15
80 RESPONSE TO GROWTH FACTOR 129 475 1.006e-16 5.854e-15
81 RESPONSE TO EXTERNAL STIMULUS 357 1821 1.304e-16 7.492e-15
82 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 57 138 1.362e-16 7.728e-15
83 CELL ACTIVATION 146 568 1.696e-16 9.507e-15
84 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 188 801 1.796e-16 9.951e-15
85 MUSCLE TISSUE DEVELOPMENT 88 275 2.23e-16 1.221e-14
86 ACTIN FILAMENT BASED PROCESS 123 450 3.102e-16 1.678e-14
87 NEURON PROJECTION MORPHOGENESIS 113 402 5.858e-16 3.133e-14
88 POSITIVE REGULATION OF MAPK CASCADE 126 470 6.837e-16 3.615e-14
89 REGULATION OF SYSTEM PROCESS 133 507 6.925e-16 3.621e-14
90 HEAD DEVELOPMENT 169 709 1.457e-15 7.531e-14
91 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 220 1004 1.514e-15 7.742e-14
92 IMMUNE SYSTEM DEVELOPMENT 146 582 1.558e-15 7.797e-14
93 REGULATION OF CELL DEATH 297 1472 1.547e-15 7.797e-14
94 MUSCLE CELL DIFFERENTIATION 78 237 1.994e-15 9.871e-14
95 CYTOSKELETON ORGANIZATION 191 838 2.32e-15 1.136e-13
96 REGULATION OF KINASE ACTIVITY 180 776 2.705e-15 1.311e-13
97 ORGAN MORPHOGENESIS 191 841 3.367e-15 1.615e-13
98 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 98 337 4.918e-15 2.335e-13
99 IMMUNE SYSTEM PROCESS 375 1984 6.581e-15 3.093e-13
100 MUSCLE ORGAN DEVELOPMENT 85 277 1.115e-14 5.186e-13
101 TUBE DEVELOPMENT 138 552 1.271e-14 5.857e-13
102 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 342 1784 1.734e-14 7.909e-13
103 CELL PROJECTION ORGANIZATION 199 902 1.86e-14 8.401e-13
104 TAXIS 121 464 2.298e-14 1.028e-12
105 POSITIVE REGULATION OF TRANSPORT 204 936 3.092e-14 1.37e-12
106 REGULATION OF NEURON PROJECTION DEVELOPMENT 110 408 3.237e-14 1.421e-12
107 LEUKOCYTE DIFFERENTIATION 87 292 3.643e-14 1.584e-12
108 REGULATION OF ACTIN FILAMENT BASED PROCESS 91 312 3.838e-14 1.654e-12
109 CONNECTIVE TISSUE DEVELOPMENT 66 194 4.839e-14 2.066e-12
110 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 68 204 6.221e-14 2.632e-12
111 STRIATED MUSCLE CELL DIFFERENTIATION 61 173 7.066e-14 2.962e-12
112 POSITIVE REGULATION OF CELL DEVELOPMENT 121 472 8.548e-14 3.551e-12
113 POSITIVE REGULATION OF NEURON DIFFERENTIATION 89 306 8.758e-14 3.606e-12
114 RESPONSE TO ORGANIC CYCLIC COMPOUND 199 917 1.013e-13 4.133e-12
115 RESPONSE TO WOUNDING 137 563 1.475e-13 5.963e-12
116 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 133 541 1.5e-13 5.963e-12
117 CELLULAR RESPONSE TO PEPTIDE 82 274 1.512e-13 5.963e-12
118 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 133 541 1.5e-13 5.963e-12
119 EMBRYO DEVELOPMENT 194 894 2.121e-13 8.291e-12
120 REGULATION OF IMMUNE SYSTEM PROCESS 277 1403 2.346e-13 9.098e-12
121 SINGLE ORGANISM BEHAVIOR 103 384 3.032e-13 1.166e-11
122 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 72 229 3.156e-13 1.204e-11
123 NEGATIVE REGULATION OF PHOSPHORYLATION 110 422 3.643e-13 1.378e-11
124 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 112 437 7.379e-13 2.769e-11
125 POSITIVE REGULATION OF KINASE ACTIVITY 120 482 9.514e-13 3.541e-11
126 TISSUE MORPHOGENESIS 129 533 1.163e-12 4.295e-11
127 EXTRACELLULAR STRUCTURE ORGANIZATION 86 304 1.236e-12 4.528e-11
128 REGULATION OF RESPONSE TO STRESS 284 1468 1.355e-12 4.927e-11
129 REGULATION OF CELL PROJECTION ORGANIZATION 133 558 1.687e-12 6.084e-11
130 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 111 437 1.743e-12 6.237e-11
131 SINGLE ORGANISM CELL ADHESION 115 459 1.827e-12 6.49e-11
132 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 117 470 1.852e-12 6.527e-11
133 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 71 232 1.975e-12 6.909e-11
134 REGULATION OF CELLULAR COMPONENT BIOGENESIS 169 767 2.163e-12 7.512e-11
135 REGULATION OF VASCULATURE DEVELOPMENT 71 233 2.482e-12 8.556e-11
136 REGULATION OF TRANSFERASE ACTIVITY 198 946 4.079e-12 1.396e-10
137 FOREBRAIN DEVELOPMENT 95 357 4.168e-12 1.416e-10
138 RESPONSE TO LIPID 188 888 5.18e-12 1.746e-10
139 DEVELOPMENTAL GROWTH 90 333 6.082e-12 2.036e-10
140 MORPHOGENESIS OF AN EPITHELIUM 102 400 1.087e-11 3.612e-10
141 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 96 368 1.105e-11 3.647e-10
142 BEHAVIOR 123 516 1.167e-11 3.824e-10
143 NEGATIVE REGULATION OF CELL PROLIFERATION 145 643 1.424e-11 4.634e-10
144 COGNITION 73 251 1.476e-11 4.769e-10
145 CELL PART MORPHOGENESIS 143 633 1.724e-11 5.531e-10
146 LEUKOCYTE ACTIVATION 104 414 1.789e-11 5.7e-10
147 POSITIVE REGULATION OF CELL DEATH 138 605 1.912e-11 6.051e-10
148 RESPONSE TO PEPTIDE 102 404 2.041e-11 6.416e-10
149 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 192 926 2.084e-11 6.507e-10
150 RESPONSE TO ABIOTIC STIMULUS 208 1024 2.099e-11 6.513e-10
151 REGULATION OF ERK1 AND ERK2 CASCADE 70 238 2.189e-11 6.745e-10
152 GROWTH 103 410 2.231e-11 6.829e-10
153 EMBRYONIC MORPHOGENESIS 126 539 2.643e-11 8.038e-10
154 REGULATION OF EPITHELIAL CELL PROLIFERATION 79 285 3.075e-11 9.291e-10
155 POSITIVE REGULATION OF CELL ADHESION 96 376 4.08e-11 1.225e-09
156 WOUND HEALING 113 470 4.608e-11 1.374e-09
157 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 68 232 4.995e-11 1.48e-09
158 CARTILAGE DEVELOPMENT 50 147 5.555e-11 1.636e-09
159 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 77 278 5.679e-11 1.662e-09
160 NEGATIVE REGULATION OF CELL DEATH 181 872 7.365e-11 2.142e-09
161 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 180 867 8.184e-11 2.365e-09
162 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 100 404 1.075e-10 3.088e-09
163 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 111 465 1.085e-10 3.098e-09
164 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 62 207 1.321e-10 3.748e-09
165 REGULATION OF CYTOSKELETON ORGANIZATION 117 502 1.661e-10 4.685e-09
166 TELENCEPHALON DEVELOPMENT 66 228 1.725e-10 4.835e-09
167 CELL JUNCTION ASSEMBLY 45 129 1.946e-10 5.422e-09
168 CHONDROCYTE DIFFERENTIATION 28 60 2.339e-10 6.477e-09
169 NEGATIVE REGULATION OF CELL DIFFERENTIATION 135 609 2.484e-10 6.84e-09
170 REGULATION OF ANATOMICAL STRUCTURE SIZE 111 472 2.798e-10 7.66e-09
171 REGULATION OF CELL CELL ADHESION 94 380 4.035e-10 1.098e-08
172 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 20 34 4.403e-10 1.191e-08
173 REGULATION OF BLOOD CIRCULATION 78 295 4.761e-10 1.281e-08
174 CELLULAR RESPONSE TO INSULIN STIMULUS 48 146 5.022e-10 1.343e-08
175 LYMPHOCYTE DIFFERENTIATION 61 209 5.85e-10 1.555e-08
176 BONE DEVELOPMENT 50 156 6.018e-10 1.591e-08
177 TUBE MORPHOGENESIS 83 323 6.051e-10 1.591e-08
178 REGULATION OF CHEMOTAXIS 55 180 6.344e-10 1.658e-08
179 REGULATION OF MAP KINASE ACTIVITY 82 319 7.535e-10 1.959e-08
180 CELLULAR RESPONSE TO LIPID 107 457 7.655e-10 1.979e-08
181 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 51 162 8.269e-10 2.126e-08
182 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 53 172 9.23e-10 2.36e-08
183 LYMPHOCYTE ACTIVATION 86 342 9.458e-10 2.405e-08
184 REGULATION OF CYTOKINE PRODUCTION 125 563 1.044e-09 2.64e-08
185 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 134 616 1.065e-09 2.663e-08
186 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 134 616 1.065e-09 2.663e-08
187 RESPONSE TO CYTOKINE 150 714 1.394e-09 3.469e-08
188 REGULATION OF CELLULAR LOCALIZATION 240 1277 1.507e-09 3.73e-08
189 SKELETAL MUSCLE ORGAN DEVELOPMENT 45 137 1.787e-09 4.4e-08
190 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 78 303 1.811e-09 4.434e-08
191 MUSCLE CELL DEVELOPMENT 43 128 1.866e-09 4.547e-08
192 REGULATION OF HOMEOSTATIC PROCESS 104 447 1.911e-09 4.631e-08
193 CELL JUNCTION ORGANIZATION 55 185 1.935e-09 4.666e-08
194 REGULATION OF ION TRANSPORT 129 592 1.956e-09 4.692e-08
195 REGULATION OF MUSCLE SYSTEM PROCESS 57 195 1.992e-09 4.754e-08
196 INOSITOL LIPID MEDIATED SIGNALING 42 124 2.164e-09 5.137e-08
197 VESICLE MEDIATED TRANSPORT 233 1239 2.524e-09 5.961e-08
198 REGULATION OF CELL ACTIVATION 110 484 2.688e-09 6.285e-08
199 MORPHOGENESIS OF A BRANCHING STRUCTURE 51 167 2.684e-09 6.285e-08
200 RESPONSE TO OXYGEN LEVELS 79 311 2.758e-09 6.417e-08
201 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 153 740 3.03e-09 7.013e-08
202 MODULATION OF SYNAPTIC TRANSMISSION 77 301 3.113e-09 7.17e-08
203 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 36 99 3.442e-09 7.85e-08
204 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 36 99 3.442e-09 7.85e-08
205 REGULATION OF OSSIFICATION 53 178 3.565e-09 8.093e-08
206 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 48 154 3.712e-09 8.384e-08
207 REGULATION OF SYNAPTIC PLASTICITY 45 140 3.865e-09 8.688e-08
208 CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 16 25 4.432e-09 9.915e-08
209 REGULATION OF METAL ION TRANSPORT 81 325 4.493e-09 1e-07
210 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 208 1087 4.524e-09 1.002e-07
211 UROGENITAL SYSTEM DEVELOPMENT 76 299 5.328e-09 1.175e-07
212 NEURON PROJECTION GUIDANCE 58 205 5.507e-09 1.209e-07
213 CELL DEATH 194 1001 5.568e-09 1.216e-07
214 RESPONSE TO STEROID HORMONE 111 497 6.4e-09 1.385e-07
215 REGULATION OF EPITHELIAL CELL MIGRATION 50 166 6.399e-09 1.385e-07
216 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 95 406 7.045e-09 1.518e-07
217 LEUKOCYTE MIGRATION 68 259 8.296e-09 1.779e-07
218 PALLIUM DEVELOPMENT 47 153 9.028e-09 1.927e-07
219 AMINOGLYCAN BIOSYNTHETIC PROCESS 37 107 1.02e-08 2.168e-07
220 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 45 144 1.032e-08 2.183e-07
221 CELL CELL SIGNALING 155 767 1.211e-08 2.551e-07
222 SYNAPSE ORGANIZATION 45 145 1.309e-08 2.743e-07
223 LIPID PHOSPHORYLATION 35 99 1.319e-08 2.752e-07
224 LEARNING 42 131 1.373e-08 2.852e-07
225 REGULATION OF DEVELOPMENTAL GROWTH 73 289 1.409e-08 2.913e-07
226 RESPONSE TO INSULIN 57 205 1.475e-08 3.023e-07
227 EMBRYONIC ORGAN DEVELOPMENT 94 406 1.471e-08 3.023e-07
228 NEGATIVE REGULATION OF GENE EXPRESSION 268 1493 1.535e-08 3.132e-07
229 REGULATION OF HOMOTYPIC CELL CELL ADHESION 76 307 1.82e-08 3.684e-07
230 SKELETAL SYSTEM MORPHOGENESIS 56 201 1.821e-08 3.684e-07
231 CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 17 30 1.997e-08 4.023e-07
232 HEART MORPHOGENESIS 58 212 2.092e-08 4.196e-07
233 REGULATION OF PROTEIN LOCALIZATION 183 950 2.441e-08 4.874e-07
234 RAS PROTEIN SIGNAL TRANSDUCTION 44 143 2.516e-08 5.003e-07
235 NEGATIVE REGULATION OF MOLECULAR FUNCTION 203 1079 2.777e-08 5.499e-07
236 CIRCULATORY SYSTEM PROCESS 86 366 2.943e-08 5.803e-07
237 REGULATION OF CELLULAR RESPONSE TO STRESS 141 691 3.011e-08 5.911e-07
238 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 87 372 3.083e-08 6.028e-07
239 APPENDAGE DEVELOPMENT 49 169 3.513e-08 6.812e-07
240 LIMB DEVELOPMENT 49 169 3.513e-08 6.812e-07
241 MEMORY 34 98 3.632e-08 7.012e-07
242 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 40 126 4.098e-08 7.879e-07
243 REGULATION OF HEART CONTRACTION 59 221 4.146e-08 7.94e-07
244 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 35 103 4.201e-08 8.01e-07
245 CELLULAR RESPONSE TO ACID CHEMICAL 50 175 4.306e-08 8.178e-07
246 ACTOMYOSIN STRUCTURE ORGANIZATION 29 77 4.584e-08 8.671e-07
247 ENDOTHELIUM DEVELOPMENT 32 90 4.674e-08 8.805e-07
248 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 22 49 4.738e-08 8.889e-07
249 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 43 141 4.815e-08 8.998e-07
250 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 48 166 5.295e-08 9.855e-07
251 PEPTIDYL AMINO ACID MODIFICATION 164 841 5.772e-08 1.07e-06
252 MUSCLE SYSTEM PROCESS 70 282 5.851e-08 1.08e-06
253 HOMEOSTATIC PROCESS 241 1337 6.103e-08 1.122e-06
254 REGULATION OF SECRETION 141 699 6.275e-08 1.15e-06
255 POSITIVE REGULATION OF ENDOCYTOSIS 37 114 6.857e-08 1.251e-06
256 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 41 133 7.016e-08 1.275e-06
257 CARDIOCYTE DIFFERENTIATION 33 96 7.399e-08 1.34e-06
258 REGULATION OF PHOSPHOLIPASE C ACTIVITY 19 39 7.685e-08 1.386e-06
259 REGULATION OF AXONOGENESIS 48 168 7.957e-08 1.429e-06
260 ACTIVATION OF PROTEIN KINASE ACTIVITY 69 279 8.462e-08 1.514e-06
261 CELL PROLIFERATION 136 672 8.81e-08 1.571e-06
262 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 72 296 9.104e-08 1.617e-06
263 CARDIAC CHAMBER DEVELOPMENT 43 144 9.426e-08 1.668e-06
264 ARTERY DEVELOPMENT 28 75 9.688e-08 1.708e-06
265 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 267 1517 1.011e-07 1.776e-06
266 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 52 190 1.089e-07 1.906e-06
267 SENSORY ORGAN DEVELOPMENT 106 493 1.104e-07 1.924e-06
268 ACTIN FILAMENT BASED MOVEMENT 32 93 1.131e-07 1.963e-06
269 CARDIAC MUSCLE TISSUE DEVELOPMENT 42 140 1.146e-07 1.983e-06
270 REGULATION OF CELLULAR COMPONENT SIZE 79 337 1.181e-07 2.035e-06
271 REGULATION OF MEMBRANE POTENTIAL 80 343 1.236e-07 2.122e-06
272 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 116 554 1.252e-07 2.141e-06
273 REGULATION OF PROTEIN SECRETION 88 389 1.282e-07 2.186e-06
274 REGULATION OF INTRACELLULAR TRANSPORT 127 621 1.288e-07 2.187e-06
275 PEPTIDYL TYROSINE MODIFICATION 51 186 1.349e-07 2.282e-06
276 REGULATION OF RESPONSE TO WOUNDING 92 413 1.419e-07 2.392e-06
277 REGULATION OF CELL CYCLE 179 949 1.591e-07 2.673e-06
278 REGULATION OF PHOSPHOLIPASE ACTIVITY 25 64 1.676e-07 2.805e-06
279 ENDOCYTOSIS 108 509 1.697e-07 2.831e-06
280 REGULATION OF SYNAPSE ORGANIZATION 36 113 1.736e-07 2.884e-06
281 CELLULAR RESPONSE TO CYTOKINE STIMULUS 124 606 1.756e-07 2.909e-06
282 CARDIAC CHAMBER MORPHOGENESIS 34 104 1.89e-07 3.108e-06
283 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 34 104 1.89e-07 3.108e-06
284 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 21 49 2.535e-07 4.153e-06
285 NEURON MIGRATION 35 110 2.65e-07 4.327e-06
286 STEM CELL DIFFERENTIATION 51 190 2.786e-07 4.533e-06
287 FAT CELL DIFFERENTIATION 34 106 3.154e-07 5.114e-06
288 SECRETION 120 588 3.203e-07 5.174e-06
289 SECOND MESSENGER MEDIATED SIGNALING 45 160 3.283e-07 5.286e-06
290 SECRETION BY CELL 103 486 3.457e-07 5.547e-06
291 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 69 289 3.547e-07 5.671e-06
292 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 24 62 3.597e-07 5.731e-06
293 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 37 121 3.759e-07 5.969e-06
294 RESPIRATORY SYSTEM DEVELOPMENT 52 197 3.787e-07 5.993e-06
295 REGULATION OF CYTOPLASMIC TRANSPORT 102 481 3.824e-07 6.032e-06
296 REGULATION OF GROWTH 127 633 3.853e-07 6.057e-06
297 OSSIFICATION 62 251 3.932e-07 6.161e-06
298 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 44 156 4.048e-07 6.299e-06
299 PLATELET DEGRANULATION 34 107 4.047e-07 6.299e-06
300 PLASMA MEMBRANE ORGANIZATION 53 203 4.275e-07 6.63e-06
301 REGULATION OF RECEPTOR ACTIVITY 36 117 4.539e-07 7.013e-06
302 NEGATIVE REGULATION OF LOCOMOTION 64 263 4.552e-07 7.013e-06
303 REGULATION OF MUSCLE TISSUE DEVELOPMENT 33 103 4.82e-07 7.402e-06
304 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 56 220 5.011e-07 7.669e-06
305 REGULATION OF MUSCLE CONTRACTION 42 147 5.03e-07 7.674e-06
306 CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS 19 43 5.292e-07 8.047e-06
307 EYE DEVELOPMENT 75 326 5.355e-07 8.117e-06
308 REGULATION OF CELL SUBSTRATE ADHESION 47 173 5.509e-07 8.323e-06
309 RHYTHMIC PROCESS 70 298 5.609e-07 8.445e-06
310 RESPONSE TO INORGANIC SUBSTANCE 101 479 5.754e-07 8.637e-06
311 ENDOTHELIAL CELL DIFFERENTIATION 26 72 5.879e-07 8.795e-06
312 POSITIVE REGULATION OF CELL CELL ADHESION 60 243 6.1e-07 9.08e-06
313 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 49 184 6.109e-07 9.08e-06
314 REGULATION OF TRANSMEMBRANE TRANSPORT 92 426 6.127e-07 9.08e-06
315 HEMOSTASIS 72 311 6.983e-07 1.031e-05
316 CELL SUBSTRATE ADHESION 45 164 7.035e-07 1.036e-05
317 REGULATION OF BINDING 67 283 7.208e-07 1.058e-05
318 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 32 100 7.367e-07 1.078e-05
319 NEGATIVE REGULATION OF KINASE ACTIVITY 61 250 7.606e-07 1.109e-05
320 GLIOGENESIS 47 175 7.897e-07 1.148e-05
321 NEGATIVE REGULATION OF CELL ADHESION 56 223 8.014e-07 1.162e-05
322 POSITIVE REGULATION OF CYTOKINE PRODUCTION 82 370 8.301e-07 1.2e-05
323 MYELOID LEUKOCYTE DIFFERENTIATION 31 96 8.751e-07 1.261e-05
324 CYTOKINE PRODUCTION 36 120 8.973e-07 1.281e-05
325 POSITIVE REGULATION OF CHEMOTAXIS 36 120 8.973e-07 1.281e-05
326 REGULATION OF DENDRITE DEVELOPMENT 36 120 8.973e-07 1.281e-05
327 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 51 197 9.227e-07 1.313e-05
328 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 53 208 9.676e-07 1.373e-05
329 REGULATION OF NEURON DEATH 61 252 1.013e-06 1.433e-05
330 REGULATION OF HEMOPOIESIS 72 314 1.022e-06 1.441e-05
331 REGULATION OF TRANSPORTER ACTIVITY 51 198 1.087e-06 1.528e-05
332 POSITIVE REGULATION OF ION TRANSPORT 58 236 1.097e-06 1.538e-05
333 GLAND MORPHOGENESIS 31 97 1.126e-06 1.574e-05
334 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 50 193 1.148e-06 1.6e-05
335 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 15 30 1.197e-06 1.658e-05
336 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 15 30 1.197e-06 1.658e-05
337 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 21 53 1.222e-06 1.678e-05
338 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 21 53 1.222e-06 1.678e-05
339 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 25 70 1.223e-06 1.678e-05
340 REGULATION OF WNT SIGNALING PATHWAY 71 310 1.267e-06 1.734e-05
341 NEGATIVE REGULATION OF CELL CYCLE 92 433 1.287e-06 1.756e-05
342 REGULATION OF MUSCLE CELL DIFFERENTIATION 42 152 1.334e-06 1.815e-05
343 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 24 66 1.368e-06 1.85e-05
344 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 24 66 1.368e-06 1.85e-05
345 REGULATION OF BODY FLUID LEVELS 104 506 1.379e-06 1.86e-05
346 B CELL ACTIVATION 38 132 1.407e-06 1.892e-05
347 MYELOID CELL DIFFERENTIATION 49 189 1.429e-06 1.917e-05
348 EPITHELIAL CELL DIFFERENTIATION 102 495 1.539e-06 2.058e-05
349 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 53 211 1.549e-06 2.065e-05
350 PEPTIDYL SERINE MODIFICATION 41 148 1.65e-06 2.181e-05
351 IMMUNE RESPONSE 197 1100 1.65e-06 2.181e-05
352 PROTEOGLYCAN BIOSYNTHETIC PROCESS 22 58 1.643e-06 2.181e-05
353 REGULATION OF STEM CELL DIFFERENTIATION 34 113 1.657e-06 2.184e-05
354 CELLULAR HOMEOSTASIS 131 676 1.78e-06 2.34e-05
355 CARDIAC SEPTUM DEVELOPMENT 28 85 1.869e-06 2.45e-05
356 CELL CYCLE ARREST 42 154 1.935e-06 2.53e-05
357 RESPONSE TO REACTIVE OXYGEN SPECIES 49 191 1.982e-06 2.584e-05
358 REGULATION OF CARTILAGE DEVELOPMENT 23 63 2.086e-06 2.712e-05
359 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 53 213 2.103e-06 2.726e-05
360 CEREBRAL CORTEX DEVELOPMENT 32 105 2.439e-06 3.153e-05
361 NEGATIVE REGULATION OF MAPK CASCADE 40 145 2.466e-06 3.178e-05
362 FORMATION OF PRIMARY GERM LAYER 33 110 2.517e-06 3.235e-05
363 ARTERY MORPHOGENESIS 20 51 2.643e-06 3.388e-05
364 REGENERATION 43 161 2.675e-06 3.42e-05
365 REGULATION OF CELL SIZE 45 172 2.902e-06 3.699e-05
366 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 77 352 2.981e-06 3.79e-05
367 REGULATION OF PROTEIN IMPORT 47 183 3.075e-06 3.898e-05
368 POSITIVE REGULATION OF GROWTH 57 238 3.223e-06 4.076e-05
369 LEUKOCYTE CELL CELL ADHESION 60 255 3.31e-06 4.173e-05
370 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 79 365 3.414e-06 4.293e-05
371 REGULATION OF DENDRITIC SPINE DEVELOPMENT 21 56 3.495e-06 4.383e-05
372 REGULATION OF LIPASE ACTIVITY 27 83 3.72e-06 4.641e-05
373 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 31 102 3.714e-06 4.641e-05
374 REGULATION OF LEUKOCYTE PROLIFERATION 51 206 3.796e-06 4.723e-05
375 CARDIAC MUSCLE CELL DIFFERENTIATION 25 74 3.921e-06 4.852e-05
376 ACTIN MEDIATED CELL CONTRACTION 25 74 3.921e-06 4.852e-05
377 ESTABLISHMENT OF CELL POLARITY 28 88 4.032e-06 4.976e-05
378 CELLULAR RESPONSE TO OXYGEN LEVELS 39 143 4.432e-06 5.456e-05
379 CHEMICAL HOMEOSTASIS 160 874 4.525e-06 5.555e-05
380 REGULATION OF MUSCLE ORGAN DEVELOPMENT 31 103 4.654e-06 5.699e-05
381 RESPONSE TO ALCOHOL 78 362 4.68e-06 5.716e-05
382 REGULATED EXOCYTOSIS 54 224 4.699e-06 5.723e-05
383 REGULATION OF JNK CASCADE 42 159 4.712e-06 5.724e-05
384 T CELL DIFFERENTIATION 35 123 4.811e-06 5.83e-05
385 MYOTUBE DIFFERENTIATION 21 57 4.855e-06 5.868e-05
386 AMEBOIDAL TYPE CELL MIGRATION 41 154 4.925e-06 5.937e-05
387 EPITHELIAL CELL DEVELOPMENT 47 186 4.961e-06 5.964e-05
388 CELLULAR RESPONSE TO EXTERNAL STIMULUS 61 264 5.122e-06 6.143e-05
389 CELLULAR CHEMICAL HOMEOSTASIS 112 570 5.137e-06 6.144e-05
390 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 25 75 5.156e-06 6.152e-05
391 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 56 236 5.282e-06 6.286e-05
392 CELLULAR RESPONSE TO AMINO ACID STIMULUS 20 53 5.313e-06 6.307e-05
393 NEURON RECOGNITION 15 33 5.439e-06 6.423e-05
394 REGULATION OF NEURON APOPTOTIC PROCESS 48 192 5.426e-06 6.423e-05
395 MESENCHYMAL CELL DIFFERENTIATION 37 134 5.649e-06 6.654e-05
396 REGULATION OF IMMUNE RESPONSE 157 858 5.707e-06 6.672e-05
397 CARDIAC SEPTUM MORPHOGENESIS 19 49 5.701e-06 6.672e-05
398 RESPONSE TO OXIDATIVE STRESS 76 352 5.703e-06 6.672e-05
399 POSITIVE REGULATION OF CELL ACTIVATION 69 311 5.748e-06 6.703e-05
400 REGULATION OF CALCIUM ION TRANSPORT 51 209 5.908e-06 6.873e-05
401 REGULATION OF ENDOTHELIAL CELL MIGRATION 33 114 5.938e-06 6.891e-05
402 AORTA DEVELOPMENT 17 41 6.057e-06 7.011e-05
403 AMINOGLYCAN METABOLIC PROCESS 43 166 6.28e-06 7.251e-05
404 RESPONSE TO DRUG 89 431 6.411e-06 7.384e-05
405 GLAND DEVELOPMENT 83 395 6.533e-06 7.505e-05
406 RESPONSE TO MECHANICAL STIMULUS 51 210 6.826e-06 7.823e-05
407 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 23 67 6.969e-06 7.948e-05
408 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 23 67 6.969e-06 7.948e-05
409 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 30 100 7.079e-06 8.053e-05
410 KIDNEY EPITHELIUM DEVELOPMENT 35 125 7.138e-06 8.101e-05
411 NEPHRON DEVELOPMENT 33 115 7.294e-06 8.258e-05
412 RESPONSE TO ACID CHEMICAL 70 319 7.361e-06 8.314e-05
413 MUSCLE CONTRACTION 55 233 7.523e-06 8.476e-05
414 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 42 162 7.822e-06 8.791e-05
415 CELLULAR RESPONSE TO CAMP 19 50 8.073e-06 9.052e-05
416 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 36 131 8.443e-06 9.444e-05
417 HEART VALVE DEVELOPMENT 15 34 8.558e-06 9.549e-05
418 REGULATION OF CHONDROCYTE DIFFERENTIATION 18 46 8.613e-06 9.587e-05
419 VASCULOGENESIS 21 59 9.099e-06 0.000101
420 MESENCHYME DEVELOPMENT 47 190 9.156e-06 0.0001014
421 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 70 321 9.211e-06 0.0001018
422 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 23 68 9.238e-06 0.0001019
423 PLATELET ACTIVATION 38 142 9.459e-06 0.000104
424 PROTEIN COMPLEX SUBUNIT ORGANIZATION 256 1527 9.521e-06 0.0001045
425 NEGATIVE REGULATION OF CELL ACTIVATION 41 158 9.743e-06 0.0001067
426 EXOCYTOSIS 68 310 1e-05 0.0001093
427 REGULATION OF ORGANELLE ORGANIZATION 204 1178 1.06e-05 0.0001155
428 REGULATION OF SYNAPSE MATURATION 9 14 1.186e-05 0.0001289
429 REGULATION OF INFLAMMATORY RESPONSE 65 294 1.192e-05 0.0001292
430 POSITIVE REGULATION OF AXONOGENESIS 23 69 1.215e-05 0.0001315
431 PROTEIN AUTOPHOSPHORYLATION 47 192 1.231e-05 0.0001329
432 REGULATION OF LEUKOCYTE MIGRATION 39 149 1.278e-05 0.0001377
433 APOPTOTIC SIGNALING PATHWAY 64 289 1.311e-05 0.0001406
434 POSITIVE REGULATION OF BLOOD CIRCULATION 28 93 1.311e-05 0.0001406
435 RESPONSE TO MONOAMINE 15 35 1.317e-05 0.0001409
436 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 16 39 1.335e-05 0.0001425
437 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 29 98 1.34e-05 0.0001427
438 MUCOPOLYSACCHARIDE METABOLIC PROCESS 31 108 1.355e-05 0.0001439
439 REGULATION OF LEUKOCYTE DIFFERENTIATION 54 232 1.392e-05 0.0001475
440 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 20 56 1.395e-05 0.0001475
441 NEGATIVE REGULATION OF NEURON DEATH 43 171 1.4e-05 0.0001477
442 CYTOKINE MEDIATED SIGNALING PATHWAY 91 452 1.454e-05 0.000153
443 CELL FATE COMMITMENT 53 227 1.518e-05 0.0001594
444 POSITIVE REGULATION OF OSSIFICATION 26 84 1.532e-05 0.0001605
445 B CELL DIFFERENTIATION 27 89 1.595e-05 0.0001667
446 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 59 262 1.66e-05 0.0001732
447 MYOFIBRIL ASSEMBLY 18 48 1.723e-05 0.0001794
448 CELL CHEMOTAXIS 41 162 1.861e-05 0.0001933
449 POSITIVE REGULATION OF LIPASE ACTIVITY 22 66 1.868e-05 0.0001936
450 SALIVARY GLAND DEVELOPMENT 14 32 1.922e-05 0.0001988
451 REGULATION OF CELL MATRIX ADHESION 27 90 1.997e-05 0.000206
452 REGULATION OF ION HOMEOSTASIS 48 201 2.014e-05 0.0002073
453 RESPONSE TO ESTROGEN 51 218 2.056e-05 0.0002112
454 AGING 59 264 2.108e-05 0.0002161
455 POSITIVE REGULATION OF MAP KINASE ACTIVITY 49 207 2.129e-05 0.0002177
456 ACTIN FILAMENT ORGANIZATION 43 174 2.212e-05 0.0002257
457 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 24 76 2.219e-05 0.0002259
458 REGULATION OF LIPID METABOLIC PROCESS 62 282 2.242e-05 0.0002278
459 MEMBRANE ASSEMBLY 12 25 2.424e-05 0.0002457
460 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 43 175 2.567e-05 0.0002596
461 NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 9 15 2.619e-05 0.0002643
462 RESPONSE TO ISCHEMIA 13 29 2.779e-05 0.0002799
463 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 16 41 2.82e-05 0.0002828
464 LUNG ALVEOLUS DEVELOPMENT 16 41 2.82e-05 0.0002828
465 DEVELOPMENTAL CELL GROWTH 24 77 2.828e-05 0.000283
466 RESPONSE TO NERVE GROWTH FACTOR 15 37 2.937e-05 0.0002926
467 AXON EXTENSION 15 37 2.937e-05 0.0002926
468 REGULATION OF OSTEOBLAST DIFFERENTIATION 31 112 2.981e-05 0.0002964
469 REGULATION OF CYTOKINE SECRETION 38 149 3.08e-05 0.0003055
470 RENAL SYSTEM PROCESS 29 102 3.086e-05 0.0003055
471 LIPID MODIFICATION 49 210 3.179e-05 0.000314
472 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 64 297 3.21e-05 0.0003164
473 LYMPHOCYTE HOMEOSTASIS 18 50 3.284e-05 0.0003201
474 WNT SIGNALING PATHWAY 73 351 3.28e-05 0.0003201
475 STAT CASCADE 18 50 3.284e-05 0.0003201
476 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 11 22 3.288e-05 0.0003201
477 JAK STAT CASCADE 18 50 3.284e-05 0.0003201
478 EMBRYONIC PLACENTA MORPHOGENESIS 11 22 3.288e-05 0.0003201
479 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 45 188 3.387e-05 0.0003284
480 GASTRULATION 39 155 3.387e-05 0.0003284
481 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 23 73 3.403e-05 0.0003292
482 PHOSPHOLIPID METABOLIC PROCESS 75 364 3.581e-05 0.0003457
483 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 17 46 3.663e-05 0.0003528
484 ORGAN REGENERATION 25 83 3.709e-05 0.0003558
485 PROTEOGLYCAN METABOLIC PROCESS 25 83 3.709e-05 0.0003558
486 MYELOID LEUKOCYTE ACTIVATION 28 98 3.808e-05 0.0003645
487 REGULATION OF CATABOLIC PROCESS 133 731 3.869e-05 0.0003697
488 SYNAPSE ASSEMBLY 22 69 4.079e-05 0.0003889
489 NEGATIVE REGULATION OF TRANSPORT 90 458 4.194e-05 0.0003991
490 PROTEIN LOCALIZATION TO CELL PERIPHERY 38 151 4.227e-05 0.0004014
491 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 15 38 4.268e-05 0.0004045
492 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 50 218 4.284e-05 0.0004051
493 MEMBRANE BIOGENESIS 13 30 4.319e-05 0.0004064
494 REGULATION OF DENDRITE MORPHOGENESIS 23 74 4.332e-05 0.0004064
495 CELL CELL JUNCTION ASSEMBLY 23 74 4.332e-05 0.0004064
496 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 13 30 4.319e-05 0.0004064
497 REGULATION OF MESENCHYMAL CELL PROLIFERATION 14 34 4.396e-05 0.0004115
498 REGULATION OF SMOOTH MUSCLE CONTRACTION 20 60 4.423e-05 0.0004124
499 LEUKOCYTE HOMEOSTASIS 20 60 4.423e-05 0.0004124
500 DENDRITE DEVELOPMENT 24 79 4.515e-05 0.0004185
501 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 24 79 4.515e-05 0.0004185
502 BONE MORPHOGENESIS 24 79 4.515e-05 0.0004185
503 GLIAL CELL DIFFERENTIATION 35 136 5.085e-05 0.0004703
504 OUTFLOW TRACT MORPHOGENESIS 19 56 5.172e-05 0.0004765
505 RECEPTOR MEDIATED ENDOCYTOSIS 52 231 5.165e-05 0.0004765
506 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 31 115 5.197e-05 0.0004779
507 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 9 16 5.29e-05 0.0004855
508 RESPONSE TO PURINE CONTAINING COMPOUND 39 158 5.356e-05 0.0004906
509 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 34 131 5.376e-05 0.0004915
510 INSULIN RECEPTOR SIGNALING PATHWAY 24 80 5.658e-05 0.000516
511 LIMBIC SYSTEM DEVELOPMENT 28 100 5.667e-05 0.000516
512 HOMEOSTASIS OF NUMBER OF CELLS 42 175 5.698e-05 0.0005178
513 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 131 724 5.728e-05 0.0005195
514 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 27 95 5.75e-05 0.0005206
515 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 26 90 5.783e-05 0.0005225
516 EYELID DEVELOPMENT IN CAMERA TYPE EYE 8 13 5.895e-05 0.0005305
517 SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE 8 13 5.895e-05 0.0005305
518 NEGATIVE REGULATION OF IMMUNE RESPONSE 32 121 5.947e-05 0.0005342
519 NEGATIVE REGULATION OF CELL DEVELOPMENT 64 303 6.044e-05 0.0005419
520 MESODERM MORPHOGENESIS 21 66 6.268e-05 0.0005587
521 REGULATION OF VASOCONSTRICTION 21 66 6.268e-05 0.0005587
522 REGULATION OF CARDIAC CONDUCTION 21 66 6.268e-05 0.0005587
523 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 12 27 6.291e-05 0.0005597
524 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 30 111 6.465e-05 0.0005741
525 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 59 274 6.542e-05 0.0005798
526 REGULATION OF CELLULAR PROTEIN LOCALIZATION 104 552 6.61e-05 0.0005847
527 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 29 106 6.687e-05 0.0005904
528 POSITIVE REGULATION OF BINDING 33 127 6.706e-05 0.000591
529 CYCLIC NUCLEOTIDE METABOLIC PROCESS 19 57 6.815e-05 0.0005994
530 REGULATION OF EXTENT OF CELL GROWTH 28 101 6.874e-05 0.0006035
531 NEGATIVE REGULATION OF CELL CELL ADHESION 35 138 7.021e-05 0.0006152
532 REGULATION OF FIBROBLAST PROLIFERATION 24 81 7.054e-05 0.000617
533 ENSHEATHMENT OF NEURONS 26 91 7.1e-05 0.0006187
534 AXON ENSHEATHMENT 26 91 7.1e-05 0.0006187
535 IN UTERO EMBRYONIC DEVELOPMENT 65 311 7.404e-05 0.0006439
536 FOREBRAIN CELL MIGRATION 20 62 7.49e-05 0.0006502
537 ADAPTIVE IMMUNE RESPONSE 61 288 8.179e-05 0.0007087
538 REGULATION OF CELL SHAPE 35 139 8.22e-05 0.0007109
539 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 28 102 8.307e-05 0.0007158
540 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 28 102 8.307e-05 0.0007158
541 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 15 40 8.589e-05 0.0007387
542 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 23 77 8.632e-05 0.0007411
543 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 25 87 8.761e-05 0.0007493
544 INTEGRIN MEDIATED SIGNALING PATHWAY 24 82 8.75e-05 0.0007493
545 PROTEIN LOCALIZATION 289 1805 8.824e-05 0.0007534
546 POSITIVE REGULATION OF AXON EXTENSION 14 36 9.288e-05 0.0007916
547 GLYCEROLIPID METABOLIC PROCESS 72 356 9.394e-05 0.0007991
548 PROTEIN DEPHOSPHORYLATION 44 190 9.448e-05 0.0008008
549 CELLULAR MACROMOLECULE LOCALIZATION 206 1234 9.443e-05 0.0008008
550 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 111 602 9.536e-05 0.0008067
551 PATTERNING OF BLOOD VESSELS 13 32 9.717e-05 0.0008191
552 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 12 28 9.704e-05 0.0008191
553 CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 9 17 9.935e-05 0.0008359
554 REGULATION OF CELL JUNCTION ASSEMBLY 21 68 0.0001018 0.0008551
555 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 34 135 0.0001027 0.0008591
556 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 34 135 0.0001027 0.0008591
557 RESPONSE TO ESTRADIOL 36 146 0.0001042 0.0008702
558 CELL MATRIX ADHESION 31 119 0.0001044 0.0008706
559 ENDOTHELIAL CELL DEVELOPMENT 16 45 0.0001058 0.0008726
560 SPROUTING ANGIOGENESIS 16 45 0.0001058 0.0008726
561 REGULATION OF DNA BINDING 26 93 0.0001057 0.0008726
562 POSITIVE REGULATION OF RECEPTOR ACTIVITY 16 45 0.0001058 0.0008726
563 EXOCRINE SYSTEM DEVELOPMENT 16 45 0.0001058 0.0008726
564 ENDOCHONDRAL BONE MORPHOGENESIS 16 45 0.0001058 0.0008726
565 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 44 191 0.0001075 0.0008835
566 REGULATION OF STEM CELL PROLIFERATION 25 88 0.0001074 0.0008835
567 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 29 109 0.0001151 0.0009431
568 RESPONSE TO HYDROGEN PEROXIDE 29 109 0.0001151 0.0009431
569 REPRODUCTIVE SYSTEM DEVELOPMENT 80 408 0.0001175 0.0009607
570 RESPONSE TO BACTERIUM 99 528 0.000118 0.0009631
571 CELL SUBSTRATE JUNCTION ASSEMBLY 15 41 0.0001192 0.0009711
572 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 34 136 0.0001199 0.0009755
573 POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 8 14 0.0001217 0.0009868
574 POSITIVE REGULATION OF FATTY ACID OXIDATION 8 14 0.0001217 0.0009868
575 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 17 50 0.0001231 0.0009943
576 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 17 50 0.0001231 0.0009943
577 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 145 829 0.0001258 0.001014
578 CHONDROCYTE DEVELOPMENT 10 21 0.0001278 0.001025
579 CELL AGGREGATION 10 21 0.0001278 0.001025
580 CARTILAGE CONDENSATION 10 21 0.0001278 0.001025
581 CORONARY VASCULATURE DEVELOPMENT 14 37 0.0001315 0.00105
582 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 14 37 0.0001315 0.00105
583 CAMP MEDIATED SIGNALING 14 37 0.0001315 0.00105
584 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 29 110 0.0001371 0.001092
585 DEVELOPMENTAL MATURATION 44 193 0.0001384 0.001101
586 INFLAMMATORY RESPONSE 87 454 0.0001392 0.001104
587 REPRODUCTION 214 1297 0.0001393 0.001104
588 RESPONSE TO CORTICOSTEROID 41 176 0.0001401 0.001109
589 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 13 33 0.0001412 0.001114
590 REGULATION OF CELL AGING 13 33 0.0001412 0.001114
591 PEPTIDYL THREONINE MODIFICATION 16 46 0.0001426 0.001123
592 REGULATION OF ENDOCYTOSIS 45 199 0.0001428 0.001123
593 SINGLE ORGANISM CELLULAR LOCALIZATION 155 898 0.0001439 0.001129
594 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 31 121 0.0001454 0.001137
595 POSITIVE REGULATION OF IMMUNE RESPONSE 104 563 0.0001454 0.001137
596 REGULATION OF DEFENSE RESPONSE 134 759 0.000148 0.001154
597 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 19 60 0.0001483 0.001154
598 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 19 60 0.0001483 0.001154
599 RESPONSE TO STARVATION 37 154 0.0001493 0.00116
600 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 30 116 0.0001541 0.001195
601 RESPONSE TO BIOTIC STIMULUS 153 886 0.000155 0.0012
602 CALCIUM ION TRANSPORT 49 223 0.0001566 0.00121
603 POSITIVE REGULATION OF DNA BINDING 15 42 0.0001631 0.001248
604 PALATE DEVELOPMENT 24 85 0.0001622 0.001248
605 CELL CYCLE G1 S PHASE TRANSITION 29 111 0.0001627 0.001248
606 NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 17 51 0.0001623 0.001248
607 G1 S TRANSITION OF MITOTIC CELL CYCLE 29 111 0.0001627 0.001248
608 NEGATIVE REGULATION OF GTPASE ACTIVITY 15 42 0.0001631 0.001248
609 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 23 80 0.0001639 0.001252
610 REGULATION OF MYELOID CELL DIFFERENTIATION 42 183 0.000166 0.001267
611 REGULATION OF FAT CELL DIFFERENTIATION 28 106 0.000171 0.0013
612 CARDIAC VENTRICLE DEVELOPMENT 28 106 0.000171 0.0013
613 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 48 218 0.0001725 0.00131
614 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 9 18 0.0001756 0.001329
615 INOSITOL PHOSPHATE MEDIATED SIGNALING 9 18 0.0001756 0.001329
616 CELLULAR RESPONSE TO STARVATION 30 117 0.0001817 0.001372
617 BONE MINERALIZATION 14 38 0.0001834 0.001383
618 REGULATION OF LEUKOCYTE CHEMOTAXIS 26 96 0.0001862 0.001402
619 POSITIVE REGULATION OF SECRETION 73 370 0.0001877 0.001411
620 RESPONSE TO ORGANOPHOSPHORUS 34 139 0.0001885 0.001415
621 RESPONSE TO AMINO ACID 29 112 0.0001925 0.001442
622 REGULATION OF CARDIAC MUSCLE CONTRACTION 20 66 0.0001969 0.001473
623 REGULATION OF HEART RATE 24 86 0.0001975 0.001475
624 ENDOMEMBRANE SYSTEM ORGANIZATION 88 465 0.0001991 0.001484
625 REGULATION OF ADAPTIVE IMMUNE RESPONSE 31 123 0.0002003 0.001491
626 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 13 34 0.0002015 0.001493
627 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 21 71 0.000201 0.001493
628 CAMP METABOLIC PROCESS 13 34 0.0002015 0.001493
629 CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 10 22 0.0002069 0.001528
630 CEREBELLAR CORTEX FORMATION 10 22 0.0002069 0.001528
631 SMOOTH MUSCLE CELL DIFFERENTIATION 12 30 0.0002144 0.001574
632 NEURON MATURATION 12 30 0.0002144 0.001574
633 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 30 118 0.0002136 0.001574
634 OSTEOCLAST DIFFERENTIATION 12 30 0.0002144 0.001574
635 REGULATION OF CELLULAR SENESCENCE 11 26 0.000218 0.001595
636 INACTIVATION OF MAPK ACTIVITY 11 26 0.000218 0.001595
637 MORPHOGENESIS OF AN EPITHELIAL SHEET 15 43 0.0002205 0.001608
638 CEREBRAL CORTEX CELL MIGRATION 15 43 0.0002205 0.001608
639 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 44 197 0.0002255 0.001642
640 REGULATION OF PEPTIDE TRANSPORT 54 256 0.0002263 0.001643
641 DIVALENT INORGANIC CATION TRANSPORT 56 268 0.0002263 0.001643
642 IMMUNE EFFECTOR PROCESS 91 486 0.0002288 0.001659
643 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 8 15 0.0002309 0.001671
644 ADULT BEHAVIOR 33 135 0.0002355 0.001699
645 CELL GROWTH 33 135 0.0002355 0.001699
646 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 24 87 0.0002394 0.001706
647 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 24 87 0.0002394 0.001706
648 CELLULAR RESPONSE TO BIOTIC STIMULUS 38 163 0.0002371 0.001706
649 VIRAL ENTRY INTO HOST CELL 24 87 0.0002394 0.001706
650 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 24 87 0.0002394 0.001706
651 MOVEMENT IN HOST ENVIRONMENT 24 87 0.0002394 0.001706
652 ENTRY INTO HOST 24 87 0.0002394 0.001706
653 ENTRY INTO HOST CELL 24 87 0.0002394 0.001706
654 INTRINSIC APOPTOTIC SIGNALING PATHWAY 36 152 0.000246 0.001748
655 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 36 152 0.000246 0.001748
656 PATTERN SPECIFICATION PROCESS 80 418 0.0002635 0.001869
657 NEPHRON EPITHELIUM DEVELOPMENT 25 93 0.0002783 0.001971
658 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 74 381 0.0002793 0.001975
659 PROTEIN O LINKED FUCOSYLATION 7 12 0.000281 0.001975
660 CELL ADHESION MEDIATED BY INTEGRIN 7 12 0.000281 0.001975
661 MECHANOSENSORY BEHAVIOR 7 12 0.000281 0.001975
662 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 121 684 0.0002806 0.001975
663 POSITIVE REGULATION OF HEART CONTRACTION 13 35 0.0002824 0.001982
664 LABYRINTHINE LAYER DEVELOPMENT 15 44 0.0002944 0.002061
665 POSITIVE REGULATION OF PROTEIN SECRETION 46 211 0.000295 0.002061
666 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 9 19 0.0002951 0.002061
667 LYMPHOCYTE COSTIMULATION 22 78 0.000304 0.002118
668 RENAL TUBULE DEVELOPMENT 22 78 0.000304 0.002118
669 POSITIVE REGULATION OF CELL GROWTH 35 148 0.0003069 0.002132
670 ORGAN GROWTH 20 68 0.0003069 0.002132
671 CARDIAC ATRIUM DEVELOPMENT 12 31 0.0003084 0.002139
672 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 69 351 0.0003089 0.002139
673 CELLULAR RESPONSE TO ALCOHOL 29 115 0.0003131 0.002165
674 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 26 99 0.0003171 0.002189
675 POSITIVE REGULATION OF HEART GROWTH 11 27 0.0003246 0.002225
676 HIPPO SIGNALING 11 27 0.0003246 0.002225
677 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 11 27 0.0003246 0.002225
678 NEUROTROPHIN SIGNALING PATHWAY 10 23 0.0003234 0.002225
679 HETEROTYPIC CELL CELL ADHESION 11 27 0.0003246 0.002225
680 CARDIAC CELL DEVELOPMENT 16 49 0.0003279 0.002244
681 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 25 94 0.0003327 0.002273
682 PROTEIN HOMOOLIGOMERIZATION 52 248 0.0003404 0.002319
683 REGULATION OF ORGAN MORPHOGENESIS 51 242 0.0003402 0.002319
684 REGULATION OF PROTEIN KINASE B SIGNALING 30 121 0.0003413 0.002321
685 ODONTOGENESIS 27 105 0.000355 0.002412
686 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 23 84 0.0003598 0.002441
687 EMBRYONIC ORGAN MORPHOGENESIS 57 279 0.0003664 0.002478
688 RESPONSE TO FIBROBLAST GROWTH FACTOR 29 116 0.0003662 0.002478
689 REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 31 127 0.000368 0.002485
690 REGULATION OF SYNAPSE ASSEMBLY 22 79 0.00037 0.002495
691 CELL CYCLE PHASE TRANSITION 53 255 0.0003755 0.002529
692 CELLULAR RESPONSE TO OXIDATIVE STRESS 41 184 0.0003811 0.002563
693 LAMELLIPODIUM ORGANIZATION 13 36 0.0003895 0.002608
694 SEMAPHORIN PLEXIN SIGNALING PATHWAY 13 36 0.0003895 0.002608
695 CORTICAL CYTOSKELETON ORGANIZATION 13 36 0.0003895 0.002608
696 DEFENSE RESPONSE 201 1231 0.0003912 0.002615
697 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 30 122 0.0003968 0.002649
698 POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 8 16 0.000409 0.002718
699 NEURON CELL CELL ADHESION 8 16 0.000409 0.002718
700 RESPONSE TO EPINEPHRINE 8 16 0.000409 0.002718
701 REGULATION OF HORMONE SECRETION 54 262 0.0004123 0.002737
702 CALCIUM MEDIATED SIGNALING 24 90 0.0004155 0.00275
703 MESONEPHROS DEVELOPMENT 24 90 0.0004155 0.00275
704 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 94 514 0.000421 0.002782
705 REGULATION OF ADHERENS JUNCTION ORGANIZATION 16 50 0.0004243 0.002797
706 RHO PROTEIN SIGNAL TRANSDUCTION 16 50 0.0004243 0.002797
707 REGULATION OF PHOSPHATASE ACTIVITY 31 128 0.0004258 0.002802
708 CELL CYCLE 213 1316 0.0004292 0.002821
709 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 37 162 0.0004348 0.002853
710 REGULATION OF PROTEIN BINDING 38 168 0.0004489 0.002936
711 SYSTEM PROCESS 280 1785 0.0004489 0.002936
712 DIVALENT INORGANIC CATION HOMEOSTASIS 67 343 0.0004492 0.002936
713 MULTICELLULAR ORGANISMAL SIGNALING 30 123 0.0004602 0.003003
714 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 18 60 0.0004629 0.003016
715 NEURAL PRECURSOR CELL PROLIFERATION 20 70 0.0004671 0.00304
716 POSITIVE REGULATION OF CYTOKINE SECRETION 25 96 0.0004702 0.003056
717 REGULATION OF FATTY ACID OXIDATION 11 28 0.0004719 0.003058
718 REGULATION OF SPROUTING ANGIOGENESIS 11 28 0.0004719 0.003058
719 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 10 24 0.0004897 0.003165
720 REGULATION OF ANOIKIS 10 24 0.0004897 0.003165
721 REGULATION OF SEQUESTERING OF CALCIUM ION 27 107 0.0004904 0.003165
722 REGULATION OF BLOOD PRESSURE 38 169 0.0005074 0.00327
723 POSITIVE REGULATION OF CELL CYCLE 65 332 0.0005082 0.00327
724 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 23 86 0.0005191 0.003336
725 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 35 152 0.0005219 0.00335
726 CELLULAR RESPONSE TO STRESS 248 1565 0.0005319 0.003409
727 OVULATION CYCLE 28 113 0.0005344 0.00342
728 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 13 0.0005401 0.003444
729 REGULATION OF CYTOPLASMIC TRANSLATION 7 13 0.0005401 0.003444
730 REGULATION OF JUN KINASE ACTIVITY 22 81 0.0005404 0.003444
731 PROTEIN OLIGOMERIZATION 81 434 0.0005434 0.003459
732 REGULATION OF INTERLEUKIN 12 PRODUCTION 16 51 0.0005441 0.003459
733 REGULATION OF INTERFERON GAMMA PRODUCTION 25 97 0.000556 0.003525
734 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 25 97 0.000556 0.003525
735 REGULATION OF CALCIUM MEDIATED SIGNALING 21 76 0.0005582 0.003529
736 MULTICELLULAR ORGANISM GROWTH 21 76 0.0005582 0.003529
737 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 18 61 0.0005774 0.003635
738 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 18 61 0.0005774 0.003635
739 POSITIVE REGULATION OF STEM CELL PROLIFERATION 18 61 0.0005774 0.003635
740 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 24 92 0.0005885 0.0037
741 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 32 136 0.0005966 0.003741
742 RESPONSE TO KETONE 40 182 0.0005964 0.003741
743 DENDRITE MORPHOGENESIS 14 42 0.0006032 0.003767
744 POSITIVE REGULATION OF GLUCOSE TRANSPORT 14 42 0.0006032 0.003767
745 EMBRYONIC EYE MORPHOGENESIS 12 33 0.0006032 0.003767
746 STEROID HORMONE MEDIATED SIGNALING PATHWAY 30 125 0.0006144 0.003832
747 REGULATION OF FATTY ACID METABOLIC PROCESS 23 87 0.0006197 0.003855
748 TISSUE REMODELING 23 87 0.0006197 0.003855
749 DIGESTIVE SYSTEM DEVELOPMENT 34 148 0.0006501 0.004038
750 TYROSINE PHOSPHORYLATION OF STAT PROTEIN 6 10 0.0006509 0.004038
751 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 15 47 0.0006568 0.004069
752 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 11 29 0.0006712 0.004125
753 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 11 29 0.0006712 0.004125
754 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 11 29 0.0006712 0.004125
755 CARDIAC MUSCLE CELL CONTRACTION 11 29 0.0006712 0.004125
756 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 11 29 0.0006712 0.004125
757 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 27 109 0.0006691 0.004125
758 ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS 35 154 0.0006728 0.00413
759 MICROTUBULE CYTOSKELETON ORGANIZATION 67 348 0.0006751 0.004139
760 REGULATION OF RECEPTOR BINDING 8 17 0.0006842 0.004172
761 NEGATIVE REGULATION OF ANOIKIS 8 17 0.0006842 0.004172
762 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 8 17 0.0006842 0.004172
763 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 8 17 0.0006842 0.004172
764 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 16 52 0.0006917 0.004207
765 ACTIVATION OF MAPKK ACTIVITY 16 52 0.0006917 0.004207
766 REGULATION OF WOUND HEALING 30 126 0.0007072 0.004276
767 COLLAGEN FIBRIL ORGANIZATION 13 38 0.0007091 0.004276
768 OSTEOBLAST DIFFERENTIATION 30 126 0.0007072 0.004276
769 ENDOTHELIAL CELL MIGRATION 17 57 0.0007103 0.004276
770 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 13 38 0.0007091 0.004276
771 CELLULAR RESPONSE TO GLUCAGON STIMULUS 13 38 0.0007091 0.004276
772 REGULATION OF ACTION POTENTIAL 13 38 0.0007091 0.004276
773 CELLULAR RESPONSE TO DRUG 19 67 0.0007097 0.004276
774 CARDIAC VENTRICLE MORPHOGENESIS 18 62 0.0007155 0.004301
775 LUNG CELL DIFFERENTIATION 10 25 0.0007212 0.004308
776 POSTSYNAPTIC MEMBRANE ORGANIZATION 10 25 0.0007212 0.004308
777 POSITIVE REGULATION OF PROTEIN IMPORT 26 104 0.0007186 0.004308
778 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 26 104 0.0007186 0.004308
779 RESPONSE TO CALCIUM ION 28 115 0.0007206 0.004308
780 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 38 172 0.0007254 0.004327
781 B CELL HOMEOSTASIS 9 21 0.0007344 0.004359
782 REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 9 21 0.0007344 0.004359
783 CELL DIFFERENTIATION IN HINDBRAIN 9 21 0.0007344 0.004359
784 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 9 21 0.0007344 0.004359
785 CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 105 595 0.00075 0.004446
786 EMBRYONIC PLACENTA DEVELOPMENT 22 83 0.0007753 0.004584
787 REGULATION OF POTASSIUM ION TRANSPORT 22 83 0.0007753 0.004584
788 ION HOMEOSTASIS 102 576 0.0007852 0.004637
789 CELL FATE DETERMINATION 14 43 0.0007879 0.004647
790 ACTION POTENTIAL 24 94 0.000821 0.004836
791 RESPONSE TO FLUID SHEAR STRESS 12 34 0.0008223 0.004837
792 HIPPOCAMPUS DEVELOPMENT 20 73 0.0008417 0.004945
793 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 70 370 0.0008547 0.005015
794 REGULATION OF ACTIN FILAMENT LENGTH 35 156 0.0008608 0.005038
795 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 35 156 0.0008608 0.005038
796 NEURON PROJECTION EXTENSION 16 53 0.000872 0.005072
797 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 16 53 0.000872 0.005072
798 CYTOSOLIC CALCIUM ION TRANSPORT 16 53 0.000872 0.005072
799 MESONEPHRIC TUBULE MORPHOGENESIS 16 53 0.000872 0.005072
800 SKELETAL MUSCLE CELL DIFFERENTIATION 16 53 0.000872 0.005072
801 REGULATION OF MUSCLE ADAPTATION 18 63 0.0008809 0.005117
802 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 29 122 0.0008842 0.00513
803 RESPONSE TO EXTRACELLULAR STIMULUS 81 441 0.0008897 0.005155
804 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 37 168 0.0008988 0.005202
805 PEPTIDYL TYROSINE DEPHOSPHORYLATION 25 100 0.0009006 0.005206
806 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 33 145 0.0009192 0.005306
807 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 22 84 0.0009227 0.005314
808 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 22 84 0.0009227 0.005314
809 CEREBELLAR CORTEX MORPHOGENESIS 11 30 0.0009356 0.005341
810 NEGATIVE REGULATION OF CELL MATRIX ADHESION 11 30 0.0009356 0.005341
811 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 11 30 0.0009356 0.005341
812 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 11 30 0.0009356 0.005341
813 ESTABLISHMENT OF ENDOTHELIAL BARRIER 11 30 0.0009356 0.005341
814 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 30 128 0.0009304 0.005341
815 LAMELLIPODIUM ASSEMBLY 11 30 0.0009356 0.005341
816 SULFUR COMPOUND CATABOLIC PROCESS 13 39 0.0009377 0.005347
817 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 7 14 0.0009585 0.005419
818 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 7 14 0.0009585 0.005419
819 NEGATIVE REGULATION OF JUN KINASE ACTIVITY 7 14 0.0009585 0.005419
820 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 7 14 0.0009585 0.005419
821 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 7 14 0.0009585 0.005419
822 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 7 14 0.0009585 0.005419
823 REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 7 14 0.0009585 0.005419
824 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 28 117 0.0009613 0.005428
825 REGULATION OF CELL GROWTH 73 391 0.0009823 0.00554
826 REGULATION OF VESICLE MEDIATED TRANSPORT 84 462 0.0009903 0.005578
827 VASCULAR PROCESS IN CIRCULATORY SYSTEM 36 163 0.0009915 0.005578
828 ENDOCRINE SYSTEM DEVELOPMENT 29 123 0.001015 0.005697
829 CELL CYCLE PROCESS 176 1081 0.001015 0.005697
830 POSITIVE REGULATION OF MUSCLE CONTRACTION 14 44 0.001018 0.005708
831 REGULATION OF TYPE 2 IMMUNE RESPONSE 10 26 0.001036 0.005785
832 MESODERMAL CELL DIFFERENTIATION 10 26 0.001036 0.005785
833 MYELOID DENDRITIC CELL ACTIVATION 10 26 0.001036 0.005785
834 SYNAPTIC SIGNALING 78 424 0.001046 0.005836
835 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 25 101 0.001051 0.005848
836 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 25 101 0.001051 0.005848
837 ION TRANSPORT 202 1262 0.001059 0.005888
838 GLOMERULUS DEVELOPMENT 15 49 0.001068 0.005928
839 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 18 64 0.001078 0.005979
840 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 9 22 0.0011 0.005991
841 BONE CELL DEVELOPMENT 9 22 0.0011 0.005991
842 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 22 85 0.001094 0.005991
843 POSITIVE REGULATION OF HEART RATE 9 22 0.0011 0.005991
844 SMOOTH MUSCLE TISSUE DEVELOPMENT 8 18 0.001091 0.005991
845 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 17 59 0.001093 0.005991
846 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 8 18 0.001091 0.005991
847 REGULATION OF B CELL APOPTOTIC PROCESS 8 18 0.001091 0.005991
848 VENTRICULAR SEPTUM DEVELOPMENT 16 54 0.001091 0.005991
849 ALPHA BETA T CELL ACTIVATION 16 54 0.001091 0.005991
850 REGULATION OF DEPHOSPHORYLATION 35 158 0.001093 0.005991
851 PROTEIN LOCALIZATION TO CELL SURFACE 9 22 0.0011 0.005991
852 CELLULAR RESPONSE TO INTERLEUKIN 6 9 22 0.0011 0.005991
853 AORTA MORPHOGENESIS 9 22 0.0011 0.005991
854 MUSCLE CELL MIGRATION 8 18 0.001091 0.005991
855 POSITIVE REGULATION OF VASOCONSTRICTION 12 35 0.001104 0.006001
856 CLATHRIN MEDIATED ENDOCYTOSIS 12 35 0.001104 0.006001
857 MESODERM DEVELOPMENT 28 118 0.001106 0.006005
858 METAL ION TRANSPORT 102 582 0.00112 0.006075
859 ADULT LOCOMOTORY BEHAVIOR 21 80 0.001156 0.006264
860 REGULATION OF HORMONE LEVELS 86 478 0.001203 0.006509
861 BIOMINERAL TISSUE DEVELOPMENT 20 75 0.001215 0.006552
862 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 20 75 0.001215 0.006552
863 NEURAL CREST CELL DIFFERENTIATION 20 75 0.001215 0.006552
864 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 13 40 0.001225 0.006589
865 ENDODERMAL CELL DIFFERENTIATION 13 40 0.001225 0.006589
866 CALCIUM ION TRANSMEMBRANE TRANSPORT 35 159 0.001229 0.006604
867 POSITIVE REGULATION OF SYNAPSE MATURATION 6 11 0.001274 0.006803
868 BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS 6 11 0.001274 0.006803
869 NEGATIVE REGULATION OF CELLULAR SENESCENCE 6 11 0.001274 0.006803
870 REGULATION OF INTERFERON GAMMA SECRETION 6 11 0.001274 0.006803
871 CARDIAC CHAMBER FORMATION 6 11 0.001274 0.006803
872 REGULATION OF INTERLEUKIN 4 PRODUCTION 11 31 0.001281 0.006825
873 REGULATION OF SYNAPTIC VESICLE TRANSPORT 11 31 0.001281 0.006825
874 THYMOCYTE AGGREGATION 14 45 0.001302 0.006926
875 T CELL DIFFERENTIATION IN THYMUS 14 45 0.001302 0.006926
876 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 26 108 0.001307 0.006942
877 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 18 65 0.001311 0.00695
878 PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 18 65 0.001311 0.00695
879 REGULATION OF GLUCOSE IMPORT 17 60 0.001342 0.007103
880 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 15 50 0.001343 0.007103
881 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 16 55 0.001354 0.007145
882 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 16 55 0.001354 0.007145
883 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 21 81 0.001372 0.007221
884 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 21 81 0.001372 0.007221
885 REGULATION OF CIRCADIAN RHYTHM 25 103 0.001417 0.007441
886 REGULATION OF CALCIUM ION IMPORT 25 103 0.001417 0.007441
887 HINDBRAIN DEVELOPMENT 31 137 0.001425 0.007467
888 REGULATION OF PROTEIN TARGETING 59 307 0.001424 0.007467
889 ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 10 27 0.001454 0.007575
890 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 28 120 0.001453 0.007575
891 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 10 27 0.001454 0.007575
892 SARCOMERE ORGANIZATION 10 27 0.001454 0.007575
893 MOTOR NEURON AXON GUIDANCE 10 27 0.001454 0.007575
894 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 12 36 0.001461 0.007597
895 NEGATIVE REGULATION OF BLOOD CIRCULATION 12 36 0.001461 0.007597
896 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 32 143 0.001464 0.007602
897 RESPONSE TO METAL ION 63 333 0.001504 0.007802
898 SKIN EPIDERMIS DEVELOPMENT 19 71 0.001523 0.007889
899 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 43 209 0.001565 0.00809
900 REGULATION OF LYMPHOCYTE DIFFERENTIATION 30 132 0.001567 0.00809
901 MAINTENANCE OF CELL NUMBER 30 132 0.001567 0.00809
902 REGULATION OF PROTEIN POLYMERIZATION 37 173 0.001574 0.008111
903 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 42 203 0.001574 0.008111
904 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 13 41 0.001582 0.008114
905 REGULATION OF DNA METABOLIC PROCESS 64 340 0.001578 0.008114
906 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 13 41 0.001582 0.008114
907 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 13 41 0.001582 0.008114
908 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 7 15 0.001595 0.00812
909 ADRENERGIC RECEPTOR SIGNALING PATHWAY 9 23 0.001599 0.00812
910 REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 7 15 0.001595 0.00812
911 RESPONSE TO INTERLEUKIN 1 27 115 0.001587 0.00812
912 REGULATION OF OSTEOBLAST PROLIFERATION 9 23 0.001599 0.00812
913 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 7 15 0.001595 0.00812
914 AMINO ACID IMPORT 7 15 0.001595 0.00812
915 REGULATION OF ALPHA BETA T CELL PROLIFERATION 9 23 0.001599 0.00812
916 REGULATION OF RESPIRATORY GASEOUS EXCHANGE 9 23 0.001599 0.00812
917 CELLULAR LIPID METABOLIC PROCESS 150 913 0.001614 0.008191
918 KIDNEY MORPHOGENESIS 21 82 0.001621 0.008207
919 CARDIAC CONDUCTION 21 82 0.001621 0.008207
920 MEMBRANE DEPOLARIZATION 17 61 0.001637 0.008275
921 RESPONSE TO CAMP 25 104 0.001638 0.008275
922 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 23 93 0.001654 0.00831
923 NEGATIVE REGULATION OF DEFENSE RESPONSE 32 144 0.001651 0.00831
924 MULTICELLULAR ORGANISM METABOLIC PROCESS 23 93 0.001654 0.00831
925 POSITIVE REGULATION OF PHAGOCYTOSIS 14 46 0.00165 0.00831
926 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 32 144 0.001651 0.00831
927 DENDRITIC SPINE DEVELOPMENT 8 19 0.00167 0.008342
928 POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION 8 19 0.00167 0.008342
929 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 46 228 0.001671 0.008342
930 NEURONAL STEM CELL POPULATION MAINTENANCE 8 19 0.00167 0.008342
931 REGULATION OF LONG TERM SYNAPTIC POTENTIATION 8 19 0.00167 0.008342
932 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 8 19 0.00167 0.008342
933 REGULATION OF ORGAN FORMATION 11 32 0.001723 0.008558
934 EPIDERMIS DEVELOPMENT 50 253 0.00172 0.008558
935 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 11 32 0.001723 0.008558
936 NEGATIVE REGULATION OF ION TRANSPORT 29 127 0.001721 0.008558
937 ADIPOSE TISSUE DEVELOPMENT 11 32 0.001723 0.008558
938 POSITIVE REGULATION OF RESPONSE TO WOUNDING 35 162 0.001728 0.008573
939 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 24 99 0.001777 0.008805
940 REGULATION OF CATION CHANNEL ACTIVITY 22 88 0.001779 0.008807
941 ENERGY RESERVE METABOLIC PROCESS 19 72 0.001819 0.008995
942 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 43 211 0.001897 0.00937
943 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 12 37 0.001909 0.009388
944 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 12 37 0.001909 0.009388
945 GLIAL CELL MIGRATION 12 37 0.001909 0.009388
946 CARDIAC MUSCLE CELL ACTION POTENTIAL 12 37 0.001909 0.009388
947 RESPONSE TO BMP 23 94 0.001924 0.009441
948 CELLULAR RESPONSE TO BMP STIMULUS 23 94 0.001924 0.009441
949 LOCOMOTORY BEHAVIOR 38 181 0.001949 0.009555
950 REGULATION OF SMOOTHENED SIGNALING PATHWAY 17 62 0.001985 0.009724
951 DEPHOSPHORYLATION 55 286 0.00199 0.009736
952 VENTRICULAR SEPTUM MORPHOGENESIS 10 28 0.001999 0.009752
953 RIBONUCLEOTIDE CATABOLIC PROCESS 10 28 0.001999 0.009752
954 LONG TERM MEMORY 10 28 0.001999 0.009752
955 INTERACTION WITH HOST 30 134 0.002006 0.009775
956 REGULATION OF HEART GROWTH 13 42 0.00202 0.009833
957 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 16 57 0.002044 0.009936
NumGOOverlapSizeP ValueAdj. P Value
1 CYTOSKELETAL PROTEIN BINDING 210 819 3.607e-23 3.351e-20
2 ENZYME BINDING 365 1737 3.591e-22 1.668e-19
3 ACTIN BINDING 122 393 5.815e-21 1.801e-18
4 PROTEIN COMPLEX BINDING 224 935 1.266e-20 2.353e-18
5 MACROMOLECULAR COMPLEX BINDING 304 1399 1.061e-20 2.353e-18
6 KINASE ACTIVITY 196 842 9.807e-17 1.519e-14
7 PROTEIN DOMAIN SPECIFIC BINDING 156 624 2.239e-16 2.972e-14
8 KINASE BINDING 152 606 4.05e-16 4.703e-14
9 MOLECULAR FUNCTION REGULATOR 279 1353 7.34e-16 7.577e-14
10 PROTEIN KINASE ACTIVITY 157 640 1.084e-15 1.007e-13
11 RECEPTOR BINDING 296 1476 3.962e-15 3.346e-13
12 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 70 228 2.384e-12 1.846e-10
13 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 205 992 5.748e-12 4.107e-10
14 CALCIUM ION BINDING 155 697 8.684e-12 5.762e-10
15 GROWTH FACTOR BINDING 45 123 3.111e-11 1.927e-09
16 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 82 303 4.899e-11 2.844e-09
17 TRANSCRIPTION FACTOR BINDING 122 524 7.23e-11 3.951e-09
18 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 34 81 1.058e-10 5.462e-09
19 CELL ADHESION MOLECULE BINDING 57 186 2.75e-10 1.344e-08
20 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 82 328 3.098e-09 1.439e-07
21 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 82 329 3.606e-09 1.523e-07
22 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 29 70 3.556e-09 1.523e-07
23 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 27 64 7.629e-09 3.082e-07
24 ENZYME REGULATOR ACTIVITY 186 959 1.101e-08 4.262e-07
25 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 77 315 2.633e-08 9.407e-07
26 PROTEIN SERINE THREONINE KINASE ACTIVITY 100 445 2.588e-08 9.407e-07
27 SH3 DOMAIN BINDING 38 116 3.464e-08 1.192e-06
28 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 129 629 8.672e-08 2.877e-06
29 GLYCOSAMINOGLYCAN BINDING 55 205 9.84e-08 3.047e-06
30 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 59 226 9.767e-08 3.047e-06
31 IDENTICAL PROTEIN BINDING 219 1209 1.738e-07 5.207e-06
32 BINDING BRIDGING 48 173 2.115e-07 6.083e-06
33 RIBONUCLEOTIDE BINDING 316 1860 2.161e-07 6.083e-06
34 INTEGRIN BINDING 34 105 2.447e-07 6.687e-06
35 PROTEIN TYROSINE KINASE ACTIVITY 48 176 3.703e-07 9.829e-06
36 ENZYME ACTIVATOR ACTIVITY 100 471 4.678e-07 1.207e-05
37 PHOSPHOLIPID BINDING 81 360 5.066e-07 1.272e-05
38 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 19 43 5.292e-07 1.294e-05
39 SMAD BINDING 26 72 5.879e-07 1.4e-05
40 ION CHANNEL BINDING 34 111 1.052e-06 2.384e-05
41 LIPID BINDING 129 657 1.047e-06 2.384e-05
42 ADENYL NUCLEOTIDE BINDING 260 1514 1.213e-06 2.683e-05
43 REGULATORY REGION NUCLEIC ACID BINDING 154 818 1.332e-06 2.877e-05
44 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 10 15 2.303e-06 4.862e-05
45 PROTEIN COMPLEX SCAFFOLD 24 68 2.532e-06 5.227e-05
46 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 20 51 2.643e-06 5.338e-05
47 CYTOKINE BINDING 29 92 3.371e-06 6.664e-05
48 SIGNALING ADAPTOR ACTIVITY 25 74 3.921e-06 7.588e-05
49 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 25 76 6.737e-06 0.0001277
50 TUBULIN BINDING 62 273 7.733e-06 0.0001437
51 HEPARIN BINDING 41 157 8.243e-06 0.0001501
52 DOUBLE STRANDED DNA BINDING 141 764 1.089e-05 0.0001946
53 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 30 104 1.667e-05 0.0002922
54 BHLH TRANSCRIPTION FACTOR BINDING 13 28 1.742e-05 0.0002996
55 ACTIVATING TRANSCRIPTION FACTOR BINDING 20 57 1.887e-05 0.000313
56 ZINC ION BINDING 199 1155 1.88e-05 0.000313
57 ACTIN FILAMENT BINDING 33 121 2.336e-05 0.0003808
58 PHOSPHORIC ESTER HYDROLASE ACTIVITY 76 368 2.936e-05 0.0004626
59 PHOSPHATIDYLSERINE BINDING 14 33 2.938e-05 0.0004626
60 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 111 588 3.5e-05 0.0005419
61 PHOSPHATIDYLINOSITOL BINDING 47 200 3.772e-05 0.000574
62 GROWTH FACTOR RECEPTOR BINDING 34 129 3.831e-05 0.000574
63 PROTEIN KINASE A BINDING 16 42 4.005e-05 0.0005906
64 PHOSPHATASE BINDING 40 162 4.293e-05 0.0006158
65 MICROTUBULE BINDING 47 201 4.309e-05 0.0006158
66 BETA CATENIN BINDING 25 84 4.632e-05 0.0006519
67 TRANSFORMING GROWTH FACTOR BETA BINDING 9 16 5.29e-05 0.0007335
68 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 34 133 7.467e-05 0.00102
69 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 18 53 7.974e-05 0.001074
70 FIBRONECTIN BINDING 12 28 9.704e-05 0.001288
71 PROTEIN HOMODIMERIZATION ACTIVITY 129 722 0.0001154 0.00151
72 CORE PROMOTER PROXIMAL REGION DNA BINDING 74 371 0.0001197 0.001544
73 TRANSCRIPTION COACTIVATOR BINDING 7 11 0.000132 0.001658
74 SEMAPHORIN RECEPTOR ACTIVITY 7 11 0.000132 0.001658
75 TRANSITION METAL ION BINDING 229 1400 0.000139 0.001722
76 METALLOPEPTIDASE ACTIVITY 43 188 0.0001516 0.001854
77 PROTEIN DIMERIZATION ACTIVITY 192 1149 0.0001545 0.001861
78 COLLAGEN BINDING 20 65 0.0001562 0.001861
79 PDZ DOMAIN BINDING 25 90 0.0001591 0.001871
80 GTPASE BINDING 61 295 0.0001653 0.00192
81 RECEPTOR SIGNALING PROTEIN ACTIVITY 40 172 0.0001744 0.002
82 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 41 178 0.0001817 0.002053
83 CORECEPTOR ACTIVITY 14 38 0.0001834 0.002053
84 DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 39 167 0.0001904 0.002105
85 SH3 SH2 ADAPTOR ACTIVITY 17 52 0.0002121 0.002318
86 METALLOENDOPEPTIDASE ACTIVITY 29 113 0.0002271 0.002453
87 PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 8 15 0.0002309 0.002466
88 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 80 417 0.0002437 0.002573
89 SULFUR COMPOUND BINDING 50 234 0.000275 0.00287
90 PROTEIN PHOSPHATASE BINDING 30 120 0.0002927 0.003012
91 NITRIC OXIDE SYNTHASE BINDING 9 19 0.0002951 0.003012
92 G PROTEIN COUPLED RECEPTOR BINDING 54 259 0.0003068 0.003098
93 CAMP BINDING 10 23 0.0003234 0.003196
94 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 197 1199 0.000321 0.003196
95 KINASE INHIBITOR ACTIVITY 24 89 0.0003472 0.003359
96 CYTOKINE RECEPTOR ACTIVITY 24 89 0.0003472 0.003359
97 STEROID HORMONE RECEPTOR ACTIVITY 18 59 0.0003685 0.003529
98 CYCLIC NUCLEOTIDE BINDING 13 36 0.0003895 0.003655
99 CATION CHANNEL ACTIVITY 60 298 0.0003892 0.003655
100 LIGAND GATED CALCIUM CHANNEL ACTIVITY 8 16 0.000409 0.003799
101 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 24 90 0.0004155 0.003822
102 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 31 128 0.0004258 0.003878
103 VIRUS RECEPTOR ACTIVITY 20 70 0.0004671 0.004213
104 KINASE REGULATOR ACTIVITY 41 186 0.0004819 0.004304
105 SIGNAL TRANSDUCER ACTIVITY 272 1731 0.0004874 0.004312
106 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 23 86 0.0005191 0.00455
107 CAMP RESPONSE ELEMENT BINDING 7 13 0.0005401 0.004677
108 CYTOKINE RECEPTOR BINDING 55 271 0.0005437 0.004677
109 GROWTH FACTOR ACTIVITY 36 160 0.0006929 0.005905
110 CALMODULIN BINDING 39 179 0.0008268 0.006983
111 UBIQUITIN LIKE PROTEIN LIGASE BINDING 53 264 0.0008815 0.007377
112 STRUCTURAL CONSTITUENT OF CYTOSKELETON 25 100 0.0009006 0.00747
113 CHROMATIN BINDING 80 435 0.0009177 0.007545
114 PROTEIN C TERMINUS BINDING 40 186 0.0009339 0.00761
NumGOOverlapSizeP ValueAdj. P Value
1 CELL JUNCTION 267 1151 2.481e-22 1.449e-19
2 INTRINSIC COMPONENT OF PLASMA MEMBRANE 339 1649 5.397e-19 1.576e-16
3 ANCHORING JUNCTION 136 489 1.605e-18 3.125e-16
4 CELL PROJECTION 357 1786 5.784e-18 8.444e-16
5 SYNAPSE 180 754 1.411e-16 1.373e-14
6 CELL LEADING EDGE 104 350 1.405e-16 1.373e-14
7 NEURON PROJECTION 212 942 2.587e-16 2.158e-14
8 CYTOSKELETON 377 1967 6.128e-16 4.474e-14
9 CELL SUBSTRATE JUNCTION 112 398 7.244e-16 4.701e-14
10 NEURON PART 264 1265 1.063e-15 6.21e-14
11 CELL SURFACE 177 757 2.111e-15 1.121e-13
12 MEMBRANE REGION 240 1134 4.737e-15 2.305e-13
13 PROTEINACEOUS EXTRACELLULAR MATRIX 96 356 1.387e-12 6.233e-11
14 EXTRACELLULAR MATRIX 108 426 3.962e-12 1.653e-10
15 GOLGI APPARATUS 278 1445 4.62e-12 1.799e-10
16 ACTIN CYTOSKELETON 111 444 5.166e-12 1.886e-10
17 SIDE OF MEMBRANE 106 428 2.857e-11 9.816e-10
18 INTRACELLULAR VESICLE 245 1259 3.041e-11 9.866e-10
19 POSTSYNAPSE 95 378 1.304e-10 3.807e-09
20 SOMATODENDRITIC COMPARTMENT 143 650 1.269e-10 3.807e-09
21 PLASMA MEMBRANE REGION 188 929 2.826e-10 7.858e-09
22 EXCITATORY SYNAPSE 59 197 3.684e-10 9.778e-09
23 ACTOMYOSIN 28 62 6.043e-10 1.534e-08
24 SYNAPSE PART 133 610 1.053e-09 2.562e-08
25 PLASMA MEMBRANE PROTEIN COMPLEX 115 510 1.904e-09 4.447e-08
26 ENDOPLASMIC RETICULUM LUMEN 58 201 2.464e-09 5.535e-08
27 VACUOLE 223 1180 3.693e-09 7.987e-08
28 ENDOPLASMIC RETICULUM 292 1631 4.217e-09 8.795e-08
29 CYTOPLASMIC VESICLE PART 129 601 5.204e-09 1.048e-07
30 DENDRITE 103 451 6.549e-09 1.275e-07
31 LAMELLIPODIUM 51 172 8.164e-09 1.513e-07
32 CELL CORTEX 64 238 8.293e-09 1.513e-07
33 MEMBRANE MICRODOMAIN 73 288 1.205e-08 2.132e-07
34 CELL CELL JUNCTION 90 383 1.407e-08 2.417e-07
35 RECEPTOR COMPLEX 79 327 3.012e-08 4.886e-07
36 CELL PROJECTION PART 182 946 2.933e-08 4.886e-07
37 GOLGI APPARATUS PART 173 893 3.976e-08 6.276e-07
38 VESICLE MEMBRANE 110 512 6.652e-08 1.022e-06
39 SARCOLEMMA 39 125 1.015e-07 1.52e-06
40 CYTOPLASMIC REGION 70 287 1.222e-07 1.784e-06
41 CYTOSKELETAL PART 254 1436 1.392e-07 1.983e-06
42 AXON 92 418 2.524e-07 3.51e-06
43 CONTRACTILE FIBER 55 211 2.763e-07 3.752e-06
44 ENDOSOME 153 793 3.196e-07 4.242e-06
45 I BAND 37 121 3.759e-07 4.878e-06
46 RUFFLE 44 156 4.048e-07 5.139e-06
47 CORTICAL CYTOSKELETON 28 81 6.188e-07 7.689e-06
48 SITE OF POLARIZED GROWTH 42 149 7.488e-07 9.11e-06
49 CYTOPLASMIC SIDE OF MEMBRANE 46 170 8.19e-07 9.761e-06
50 GOLGI MEMBRANE 136 703 1.247e-06 1.456e-05
51 CORTICAL ACTIN CYTOSKELETON 22 58 1.643e-06 1.881e-05
52 CELL CORTEX PART 35 119 2.103e-06 2.361e-05
53 PERINUCLEAR REGION OF CYTOPLASM 125 642 2.393e-06 2.637e-05
54 EXTRACELLULAR MATRIX COMPONENT 36 125 2.607e-06 2.819e-05
55 MICROTUBULE CYTOSKELETON 190 1068 3.934e-06 4.177e-05
56 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 30 98 4.499e-06 4.653e-05
57 ACTIN FILAMENT 24 70 4.542e-06 4.653e-05
58 EXTRINSIC COMPONENT OF MEMBRANE 59 252 4.698e-06 4.73e-05
59 ACTIN FILAMENT BUNDLE 21 57 4.855e-06 4.806e-05
60 ENDOPLASMIC RETICULUM PART 203 1163 6.64e-06 6.463e-05
61 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 14 30 7.66e-06 7.215e-05
62 CELL BODY 99 494 7.621e-06 7.215e-05
63 LYTIC VACUOLE 104 526 8.363e-06 7.753e-05
64 NEURON SPINE 34 121 8.82e-06 7.924e-05
65 MYELIN SHEATH 43 168 8.706e-06 7.924e-05
66 EARLY ENDOSOME 66 301 1.359e-05 0.0001203
67 VACUOLAR LUMEN 32 115 1.988e-05 0.0001733
68 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 36 136 2.078e-05 0.0001785
69 SYNAPTIC MEMBRANE 58 261 2.933e-05 0.0002482
70 EXTERNAL SIDE OF PLASMA MEMBRANE 54 238 2.977e-05 0.0002484
71 LEADING EDGE MEMBRANE 35 134 3.646e-05 0.0002999
72 LYSOSOMAL LUMEN 26 88 3.785e-05 0.000307
73 FILOPODIUM 27 94 4.694e-05 0.0003755
74 PLATELET ALPHA GRANULE 23 75 5.482e-05 0.0004327
75 EXTRACELLULAR SPACE 228 1376 6.429e-05 0.0005006
76 VACUOLAR PART 126 694 6.759e-05 0.0005194
77 MAIN AXON 19 58 8.903e-05 0.0006752
78 BASEMENT MEMBRANE 26 93 0.0001057 0.0007913
79 COLLAGEN TRIMER 25 88 0.0001074 0.0007936
80 ENDOCYTIC VESICLE 55 256 0.0001208 0.0008822
81 PLATELET DENSE TUBULAR NETWORK 7 11 0.000132 0.0009404
82 SEMAPHORIN RECEPTOR COMPLEX 7 11 0.000132 0.0009404
83 TRANS GOLGI NETWORK 44 193 0.0001384 0.0009623
84 PLATELET ALPHA GRANULE LUMEN 18 55 0.0001373 0.0009623
85 AXON PART 48 219 0.0001934 0.001329
86 CELL PROJECTION MEMBRANE 61 298 0.0002206 0.001498
87 COATED PIT 20 67 0.0002466 0.001655
88 APICAL PART OF CELL 71 361 0.0002512 0.001667
89 NEURONAL POSTSYNAPTIC DENSITY 17 53 0.0002745 0.001802
90 TRANSPORT VESICLE 67 338 0.0002938 0.001906
91 SARCOPLASM 20 68 0.0003069 0.001969
92 MHC PROTEIN COMPLEX 11 27 0.0003246 0.002061
93 APICAL JUNCTION COMPLEX 31 128 0.0004258 0.002674
94 FILAMENTOUS ACTIN 9 20 0.0004744 0.002948
95 ENDOCYTIC VESICLE MEMBRANE 35 152 0.0005219 0.003142
96 COATED VESICLE 49 234 0.0005119 0.003142
97 PLASMA MEMBRANE RAFT 23 86 0.0005191 0.003142
98 CLATHRIN COATED VESICLE MEMBRANE 22 81 0.0005404 0.00322
99 ER TO GOLGI TRANSPORT VESICLE 20 71 0.0005714 0.003371
100 MICROTUBULE PLUS END 8 17 0.0006842 0.003996
101 CATION CHANNEL COMPLEX 37 167 0.0007997 0.004624
102 PHOSPHATASE COMPLEX 15 48 0.0008412 0.004816
103 COATED VESICLE MEMBRANE 32 139 0.0008875 0.005032
104 SECRETORY GRANULE 67 352 0.0009241 0.005189
105 INTERSTITIAL MATRIX 7 14 0.0009585 0.005331
106 VESICLE LUMEN 26 106 0.0009749 0.005371
107 ACTIN BASED CELL PROJECTION 39 181 0.001033 0.005638
108 MICROTUBULE 75 405 0.001069 0.005779
109 SECRETORY GRANULE LUMEN 22 85 0.001094 0.005807
110 CELL CELL ADHERENS JUNCTION 16 54 0.001091 0.005807
111 RUFFLE MEMBRANE 21 80 0.001156 0.006084
112 ORGANELLE SUBCOMPARTMENT 60 311 0.001185 0.006178
113 LATE ENDOSOME 44 213 0.001279 0.006608
114 T TUBULE 14 45 0.001302 0.006672
115 BASAL PART OF CELL 15 51 0.001676 0.008513
116 CLATHRIN COATED VESICLE 34 157 0.001912 0.009472
117 POSTSYNAPTIC MEMBRANE 42 205 0.001914 0.009472
118 TRANSPORT VESICLE MEMBRANE 33 151 0.001888 0.009472
119 SECRETORY GRANULE MEMBRANE 20 78 0.002036 0.009993

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04510_Focal_adhesion 77 200 1e-19 1.8e-17
2 hsa04151_PI3K_AKT_signaling_pathway 107 351 6.708e-18 6.037e-16
3 hsa04014_Ras_signaling_pathway 73 236 5.369e-13 3.222e-11
4 hsa04010_MAPK_signaling_pathway 77 268 8.005e-12 3.602e-10
5 hsa04810_Regulation_of_actin_cytoskeleton 65 214 2.424e-11 8.725e-10
6 hsa04514_Cell_adhesion_molecules_.CAMs. 46 136 3.982e-10 1.195e-08
7 hsa04512_ECM.receptor_interaction 34 85 5.027e-10 1.293e-08
8 hsa04390_Hippo_signaling_pathway 45 154 9.729e-08 2.135e-06
9 hsa04360_Axon_guidance 40 130 1.067e-07 2.135e-06
10 hsa04270_Vascular_smooth_muscle_contraction 35 116 1.09e-06 1.837e-05
11 hsa04020_Calcium_signaling_pathway 47 177 1.122e-06 1.837e-05
12 hsa04722_Neurotrophin_signaling_pathway 37 127 1.403e-06 2.105e-05
13 hsa04380_Osteoclast_differentiation 36 128 4.755e-06 6.584e-05
14 hsa04350_TGF.beta_signaling_pathway 27 85 6.172e-06 7.935e-05
15 hsa04540_Gap_junction 27 90 1.997e-05 0.0002396
16 hsa04070_Phosphatidylinositol_signaling_system 24 78 3.583e-05 0.000389
17 hsa04640_Hematopoietic_cell_lineage 26 88 3.785e-05 0.000389
18 hsa04062_Chemokine_signaling_pathway 45 189 3.89e-05 0.000389
19 hsa04720_Long.term_potentiation 22 70 5.221e-05 0.0004946
20 hsa04144_Endocytosis 47 203 5.597e-05 0.0005037
21 hsa04630_Jak.STAT_signaling_pathway 38 155 7.755e-05 0.0006648
22 hsa04145_Phagosome 38 156 8.979e-05 0.0007347
23 hsa04012_ErbB_signaling_pathway 24 87 0.0002394 0.001873
24 hsa04520_Adherens_junction 21 73 0.0003073 0.002305
25 hsa04910_Insulin_signaling_pathway 33 138 0.0003625 0.00261
26 hsa04916_Melanogenesis 26 101 0.0004442 0.003003
27 hsa04310_Wnt_signaling_pathway 35 151 0.0004584 0.003003
28 hsa04730_Long.term_depression 20 70 0.0004671 0.003003
29 hsa04660_T_cell_receptor_signaling_pathway 27 108 0.0005737 0.003561
30 hsa04114_Oocyte_meiosis 28 114 0.0006214 0.003729
31 hsa04971_Gastric_acid_secretion 20 74 0.001014 0.005887
32 hsa04912_GnRH_signaling_pathway 25 101 0.001051 0.005911
33 hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate 9 22 0.0011 0.005998
34 hsa04662_B_cell_receptor_signaling_pathway 20 75 0.001215 0.006434
35 hsa04914_Progesterone.mediated_oocyte_maturation 22 87 0.001519 0.00781
36 hsa04666_Fc_gamma_R.mediated_phagocytosis 23 95 0.00223 0.01111
37 hsa04920_Adipocytokine_signaling_pathway 18 68 0.002284 0.01111
38 hsa04320_Dorso.ventral_axis_formation 9 25 0.003132 0.01483
39 hsa04970_Salivary_secretion 21 89 0.004678 0.02159
40 hsa04960_Aldosterone.regulated_sodium_reabsorption 12 42 0.006115 0.02752
41 hsa04610_Complement_and_coagulation_cascades 17 69 0.006572 0.02885
42 hsa04672_Intestinal_immune_network_for_IgA_production 13 49 0.008666 0.03714
43 hsa04210_Apoptosis 20 89 0.009962 0.0417
44 hsa04612_Antigen_processing_and_presentation 18 78 0.01067 0.04363
45 hsa00562_Inositol_phosphate_metabolism 14 57 0.01331 0.05325
46 hsa04110_Cell_cycle 26 128 0.01408 0.0551
47 hsa04150_mTOR_signaling_pathway 13 52 0.01444 0.0553
48 hsa04115_p53_signaling_pathway 16 69 0.01482 0.05556
49 hsa04670_Leukocyte_transendothelial_migration 24 117 0.01589 0.05836
50 hsa04530_Tight_junction 26 133 0.02238 0.08055
51 hsa04340_Hedgehog_signaling_pathway 13 56 0.02621 0.09252
52 hsa00600_Sphingolipid_metabolism 10 40 0.02994 0.1036
53 hsa04962_Vasopressin.regulated_water_reabsorption 10 44 0.05425 0.1842
54 hsa04974_Protein_digestion_and_absorption 16 81 0.05824 0.1941
55 hsa04972_Pancreatic_secretion 19 101 0.0637 0.2085
56 hsa04370_VEGF_signaling_pathway 15 76 0.0656 0.2108
57 hsa04142_Lysosome 22 121 0.06687 0.2112
58 hsa04710_Circadian_rhythm_._mammal 6 23 0.07021 0.2179
59 hsa04664_Fc_epsilon_RI_signaling_pathway 15 79 0.08616 0.2629
60 hsa00380_Tryptophan_metabolism 9 42 0.08968 0.269
61 hsa01040_Biosynthesis_of_unsaturated_fatty_acids 5 21 0.1299 0.3832
62 hsa00770_Pantothenate_and_CoA_biosynthesis 4 16 0.147 0.4268
63 hsa00410_beta.Alanine_metabolism 5 22 0.151 0.4312
64 hsa04330_Notch_signaling_pathway 9 47 0.1533 0.4312
65 hsa00330_Arginine_and_proline_metabolism 10 54 0.1609 0.4456
66 hsa04620_Toll.like_receptor_signaling_pathway 17 102 0.1742 0.4752
67 hsa00512_Mucin_type_O.Glycan_biosynthesis 6 30 0.1905 0.5119
68 hsa00561_Glycerolipid_metabolism 9 50 0.1998 0.5244
69 hsa04260_Cardiac_muscle_contraction 13 77 0.201 0.5244
70 hsa00920_Sulfur_metabolism 3 13 0.2364 0.6057
71 hsa04650_Natural_killer_cell_mediated_cytotoxicity 21 136 0.2389 0.6057
72 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 3 15 0.3116 0.779
73 hsa00565_Ether_lipid_metabolism 6 36 0.3287 0.8105
74 hsa04621_NOD.like_receptor_signaling_pathway 9 59 0.3644 0.8744
75 hsa00230_Purine_metabolism 23 162 0.3692 0.8744
76 hsa00760_Nicotinate_and_nicotinamide_metabolism 4 24 0.3855 0.8938
77 hsa04614_Renin.angiotensin_system 3 17 0.3873 0.8938
78 hsa03015_mRNA_surveillance_pathway 12 83 0.4015 0.9052
79 hsa00250_Alanine._aspartate_and_glutamate_metabolism 5 32 0.4094 0.9052
80 hsa00640_Propanoate_metabolism 5 32 0.4094 0.9052
81 hsa00670_One_carbon_pool_by_folate 3 18 0.4245 0.9052
82 hsa00740_Riboflavin_metabolism 2 11 0.4317 0.9052
83 hsa03320_PPAR_signaling_pathway 10 70 0.4339 0.9052
84 hsa04141_Protein_processing_in_endoplasmic_reticulum 23 168 0.4403 0.9052
85 hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism 7 48 0.4409 0.9052
86 hsa00534_Glycosaminoglycan_biosynthesis_._heparan_sulfate 4 26 0.4476 0.9052
87 hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series 4 26 0.4476 0.9052
88 hsa00030_Pentose_phosphate_pathway 4 27 0.4779 0.9558
89 hsa00071_Fatty_acid_metabolism 6 43 0.4994 0.9803
90 hsa03030_DNA_replication 5 36 0.516 0.9803
91 hsa00280_Valine._leucine_and_isoleucine_degradation 6 44 0.5228 0.9803
92 hsa00310_Lysine_degradation 6 44 0.5228 0.9803
93 hsa04973_Carbohydrate_digestion_and_absorption 6 44 0.5228 0.9803
94 hsa00340_Histidine_metabolism 4 29 0.5363 0.9851
95 hsa04744_Phototransduction 4 29 0.5363 0.9851
96 hsa04622_RIG.I.like_receptor_signaling_pathway 9 71 0.5929 1
97 hsa00910_Nitrogen_metabolism 3 23 0.5944 1
98 hsa04964_Proximal_tubule_bicarbonate_reclamation 3 23 0.5944 1
99 hsa00564_Glycerophospholipid_metabolism 10 80 0.6107 1
100 hsa00350_Tyrosine_metabolism 5 41 0.6361 1
101 hsa00120_Primary_bile_acid_biosynthesis 2 16 0.6382 1
102 hsa00360_Phenylalanine_metabolism 2 17 0.6716 1
103 hsa00450_Selenocompound_metabolism 2 17 0.6716 1
104 hsa02010_ABC_transporters 5 44 0.6986 1
105 hsa00052_Galactose_metabolism 3 27 0.7044 1
106 hsa04966_Collecting_duct_acid_secretion 3 27 0.7044 1
107 hsa00270_Cysteine_and_methionine_metabolism 4 36 0.7104 1
108 hsa00500_Starch_and_sucrose_metabolism 6 54 0.7254 1
109 hsa04976_Bile_secretion 8 71 0.7263 1
110 hsa03440_Homologous_recombination 3 28 0.7281 1
111 hsa00531_Glycosaminoglycan_degradation 2 19 0.7309 1
112 hsa00592_alpha.Linolenic_acid_metabolism 2 20 0.757 1
113 hsa04623_Cytosolic_DNA.sensing_pathway 6 56 0.7577 1
114 hsa00010_Glycolysis_._Gluconeogenesis 7 65 0.7628 1
115 hsa00510_N.Glycan_biosynthesis 5 49 0.7854 1
116 hsa00260_Glycine._serine_and_threonine_metabolism 3 32 0.8079 1
117 hsa03430_Mismatch_repair 2 23 0.8225 1
118 hsa04742_Taste_transduction 5 52 0.8274 1
119 hsa00240_Pyrimidine_metabolism 10 99 0.8494 1
120 hsa03420_Nucleotide_excision_repair 4 45 0.857 1
121 hsa00982_Drug_metabolism_._cytochrome_P450 7 73 0.8572 1
122 hsa04130_SNARE_interactions_in_vesicular_transport 3 36 0.867 1
123 hsa00053_Ascorbate_and_aldarate_metabolism 2 26 0.8717 1
124 hsa04120_Ubiquitin_mediated_proteolysis 14 139 0.884 1
125 hsa00590_Arachidonic_acid_metabolism 5 59 0.8996 1
126 hsa00480_Glutathione_metabolism 4 50 0.907 1
127 hsa00620_Pyruvate_metabolism 3 40 0.9095 1
128 hsa00650_Butanoate_metabolism 2 30 0.9178 1
129 hsa00983_Drug_metabolism_._other_enzymes 4 52 0.9222 1
130 hsa00040_Pentose_and_glucuronate_interconversions 2 32 0.9345 1
131 hsa04140_Regulation_of_autophagy 2 34 0.948 1
132 hsa00514_Other_types_of_O.glycan_biosynthesis 3 46 0.9504 1
133 hsa00051_Fructose_and_mannose_metabolism 2 36 0.9588 1
134 hsa03022_Basal_transcription_factors 2 37 0.9633 1
135 hsa00830_Retinol_metabolism 4 64 0.9749 1
136 hsa04146_Peroxisome 5 79 0.9827 1
137 hsa00140_Steroid_hormone_biosynthesis 3 57 0.9846 1
138 hsa03050_Proteasome 2 45 0.9859 1
139 hsa03018_RNA_degradation 4 71 0.9876 1
140 hsa03013_RNA_transport 11 152 0.9923 1
141 hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 3 71 0.9968 1
142 hsa03040_Spliceosome 7 128 0.9986 1
143 hsa03008_Ribosome_biogenesis_in_eukaryotes 2 81 0.9998 1
144 hsa00190_Oxidative_phosphorylation 4 132 1 1
145 hsa03010_Ribosome 2 92 1 1
146 hsa04740_Olfactory_transduction 9 388 1 1

Quest ID: 4d2ba26c9f80a60bb392b86935730e75